| (+)-alpha-tocopherol | multiple interactions | ISO | RGD:11275 | 6480464 | alpha-Tocopherol inhibits the reaction [Vitamin E deficiency results in increased expression of CCL2 protein] | CTD | PMID:19735175 |
| (+)-catechin | multiple interactions | EXP | | 6480464 | Catechin inhibits the reaction [S100B protein results in increased expression of CCL2 mRNA] | CTD | PMID:17103373 |
| (+)-catechin | multiple interactions | ISO | RGD:11275 | 6480464 | [resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of CCL2 mRNA | CTD | PMID:16806235 |
| (+)-pilocarpine | decreases expression | ISO | RGD:11275 | 6480464 | Pilocarpine results in decreased expression of CCL2 protein | CTD | PMID:19490431 |
| (+)-pilocarpine | increases expression | ISO | RGD:11275 | 6480464 | Pilocarpine results in increased expression of CCL2 mRNA | CTD | PMID:19490431 PMID:15193289 |
| (+)-pilocarpine | increases expression | ISO | RGD:3645 | 6480464 | Pilocarpine results in increased expression of CCL2 protein | CTD | PMID:20034406 |
| (+)-pilocarpine | increases expression | ISO | RGD:3645 | 6480464 | Pilocarpine results in increased expression of CCL2 mRNA | CTD | PMID:17971868 |
| (+)-pilocarpine | increases expression | ISO | RGD:11275 | 6480464 | Pilocarpine results in increased expression of CCL2 mRNA | CTD | PMID:15193289 PMID:19490431 |
| (-)-anisomycin | decreases expression | EXP | | 6480464 | Anisomycin results in decreased expression of CCL2 protein | CTD | PMID:20116850 |
| (-)-epigallocatechin 3-gallate | decreases secretion | EXP | | 6480464 | epigallocatechin gallate results in decreased secretion of CCL2 protein | CTD | PMID:20816778 |
| (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CCL2 mRNA | CTD | PMID:22079256 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:11275 | 6480464 | epigallocatechin gallate inhibits the reaction [Pyruvaldehyde results in increased expression of CCL2 protein] | CTD | PMID:22101032 |
| (3S,5R)-fluvastatin | multiple interactions | ISO | RGD:3645 | 6480464 | fluvastatin inhibits the reaction [Puromycin Aminonucleoside results in increased expression of CCL2 mRNA] | CTD | PMID:16452496 |
| (R)-lipoic acid | multiple interactions | ISO | RGD:11275 | 6480464 | Thioctic Acid inhibits the reaction [arsenic trioxide results in increased expression of CCL2 mRNA] | CTD | PMID:22488045 |
| (R)-mevalonic acid | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [atorvastatin inhibits the reaction [TNF results in increased expression of CCL2 mRNA]]; more ... | CTD | PMID:12117737 |
| (R)-mevalonic acid | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased expression of CCL2 mRNA]] | CTD | PMID:12117737 PMID:16321392 |
| (R)-mevalonic acid | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [IFNG results in increased expression of CCL2 mRNA]] | CTD | PMID:16321392 |
| (S)-colchicine | increases expression | ISO | RGD:3645 | 6480464 | Colchicine results in increased expression of CCL2 mRNA | CTD | PMID:3119359 PMID:20624997 |
| (S)-colchicine | increases expression | ISO | RGD:3645 | 6480464 | Colchicine results in increased expression of CCL2 mRNA | CTD | PMID:20624997 PMID:3119359 |
| (S)-nicotine | multiple interactions | ISO | RGD:3645 | 6480464 | Mecamylamine inhibits the reaction [Nicotine results in decreased expression of CCL2 mRNA] | CTD | PMID:15135227 |
| (S)-nicotine | multiple interactions | ISO | RGD:11275 | 6480464 | Nicotine inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; more ... | CTD | PMID:22093924 |
| (S)-nicotine | decreases secretion | ISO | RGD:11275 | 6480464 | Nicotine results in decreased secretion of CCL2 protein | CTD | PMID:22093924 |
| (S)-nicotine | decreases expression | ISO | RGD:11275 | 6480464 | Nicotine results in decreased expression of CCL2 mRNA | CTD | PMID:22093924 |
| (S)-nicotine | decreases expression | ISO | RGD:3645 | 6480464 | Nicotine results in decreased expression of CCL2 protein | CTD | PMID:15976189 |
| (S)-nicotine | decreases expression | ISO | RGD:3645 | 6480464 | Nicotine results in decreased expression of CCL2 mRNA | CTD | PMID:15135227 |
| 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose | multiple interactions | EXP | | 6480464 | beta-penta-O-galloyl-glucose inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | CTD | PMID:16253226 |
| 1,2,4-trimethylbenzene | increases expression | ISO | RGD:3645 | 6480464 | pseudocumene results in increased expression of CCL2 protein | CTD | PMID:17337753 |
| 1,3-benzothiazole-2-thiol | decreases expression | EXP | | 6480464 | captax results in decreased expression of CCL2 mRNA | CTD | PMID:20713136 |
| 1,4-benzoquinone | increases expression | EXP | | 6480464 | benzoquinone results in increased expression of CCL2 protein | CTD | PMID:17572062 |
| 1,4-naphthoquinone | increases expression | EXP | | 6480464 | 1,4-naphthoquinone results in increased expression of CCL2 mRNA | CTD | PMID:23333790 |
| 1,4-phenylenediamine | increases secretion | ISO | RGD:11275 | 6480464 | 4-phenylenediamine results in increased secretion of CCL2 protein | CTD | PMID:22245253 |
| 1-chloro-2,4-dinitrobenzene | decreases expression | EXP | | 6480464 | Dinitrochlorobenzene results in decreased expression of CCL2 mRNA | CTD | PMID:17374397 |
| 1-chloro-2,4-dinitrobenzene | increases secretion | ISO | RGD:11275 | 6480464 | Dinitrochlorobenzene results in increased secretion of CCL2 protein | CTD | PMID:22245253 |
| 1-chloro-2,4-dinitrobenzene | increases expression | ISO | RGD:11275 | 6480464 | Dinitrochlorobenzene results in increased expression of CCL2 mRNA | CTD | PMID:19647056 |
| 1-chloro-2,4-dinitrobenzene | decreases expression | EXP | | 6480464 | Dinitrochlorobenzene results in decreased expression of CCL2 mRNA | CTD | PMID:17374397 PMID:20713136 |
| 1-chloro-2,4-dinitrobenzene | increases expression | EXP | | 6480464 | Dinitrochlorobenzene results in increased expression of CCL2 mRNA | CTD | PMID:15585374 |
| 1-chloro-2,4-dinitrobenzene | decreases secretion | EXP | | 6480464 | Dinitrochlorobenzene results in decreased secretion of CCL2 protein | CTD | PMID:20488241 |
| 1-chloro-2,4-dinitrobenzene | increases secretion | EXP | | 6480464 | Dinitrochlorobenzene results in increased secretion of CCL2 protein | CTD | PMID:20488241 |
| 1-fluoro-2,4-dinitrobenzene | increases expression | ISO | RGD:11275 | 6480464 | Dinitrofluorobenzene results in increased expression of CCL2 mRNA | CTD | PMID:15719370 |
| 1-fluoro-2,4-dinitrobenzene | multiple interactions | EXP | | 6480464 | [CCL2 protein results in increased expression of CCR2 protein] which affects the susceptibility to Dinitrofluorobenzene | CTD | PMID:21362464 |
| 1-naphthyl isothiocyanate | increases expression | ISO | RGD:11275 | 6480464 | 1-Naphthylisothiocyanate results in increased expression of CCL2 protein | CTD | PMID:22094456 |
| 1-naphthyl isothiocyanate | increases expression | ISO | RGD:11275 | 6480464 | 1-Naphthylisothiocyanate results in increased expression of CCL2 mRNA | CTD | PMID:21037076 |
| 1-naphthyl isothiocyanate | multiple interactions | ISO | RGD:11275 | 6480464 | F3 protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:21037076 |
| 1-naphthyl isothiocyanate | multiple interactions | ISO | RGD:11275 | 6480464 | [FGA gene mutant form results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of CCL2 mRNA | CTD | PMID:21356363 |
| 11-deoxycorticosterone | multiple interactions | ISO | RGD:3645 | 6480464 | [Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of CCL2 mRNA; more ... | CTD | PMID:21135038 |
| 17-HDoHE | multiple interactions | ISO | RGD:11275 | 6480464 | 17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | CTD | PMID:21724996 |
| 17alpha-ethynylestradiol | affects secretion | ISO | RGD:11275 | 6480464 | Ethinyl Estradiol affects the secretion of CCL2 protein | CTD | PMID:15885639 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:3645 | 6480464 | Ethinyl Estradiol affects the expression of CCL2 mRNA | CTD | PMID:17351261 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:11275 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CCL2 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:11275 | 6480464 | Ethinyl Estradiol results in increased expression of CCL2 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | decreases secretion | ISO | RGD:11275 | 6480464 | Ethinyl Estradiol results in decreased secretion of CCL2 protein | CTD | PMID:12538720 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | ESR1 protein affects the reaction [Estradiol results in decreased activity of CCL2 protein]; more ... | CTD | PMID:17006379 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | Estradiol inhibits the reaction [IL1A protein promotes the reaction [[RELA protein co-treated with NFKB1 protein] binds to CCL2 promoter]]; more ... | CTD | PMID:10614622 |
| 17beta-estradiol | multiple interactions | ISO | RGD:3645 | 6480464 | Estradiol inhibits the reaction [Estrogens deficiency results in increased expression of CCL2 protein] | CTD | PMID:19553526 |
| 17beta-estradiol | decreases secretion | ISO | RGD:11275 | 6480464 | Estradiol results in decreased secretion of CCL2 protein | CTD | PMID:12538720 |
| 17beta-estradiol | affects expression | ISO | RGD:11275 | 6480464 | Estradiol affects the expression of CCL2 mRNA | CTD | PMID:15598610 |
| 17beta-estradiol | decreases activity | EXP | | 6480464 | Estradiol results in decreased activity of CCL2 protein | CTD | PMID:17006379 |
| 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of CCL2 mRNA | CTD | PMID:14699072 |
| 17beta-hydroxy-5alpha-androstan-3-one | multiple interactions | EXP | | 6480464 | bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]]; more ... | CTD | PMID:16317058 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | increases expression | ISO | RGD:3645 | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of CCL2 mRNA | CTD | PMID:20959002 |
| 2,2'-iminobis[1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)ethanol] | decreases expression | EXP | | 6480464 | nebivolol results in decreased expression of CCL2 mRNA | CTD | PMID:17467819 |
| 2,2'-iminobis[1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)ethanol] | decreases secretion | EXP | | 6480464 | nebivolol results in decreased secretion of CCL2 protein | CTD | PMID:17310107 PMID:17467819 |
| 2,2'-iminobis[1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)ethanol] | decreases secretion | EXP | | 6480464 | nebivolol results in decreased secretion of CCL2 protein | CTD | PMID:17467819 PMID:17310107 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:11275 | 6480464 | [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA]; more ... | CTD | PMID:16054899 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:11275 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Dextran Sulfate results in increased secretion of CCL2 protein] | CTD | PMID:21858153 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases secretion | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased secretion of CCL2 protein | CTD | PMID:21685244 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:3645 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CCL2 mRNA | CTD | PMID:19692669 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CCL2 mRNA] | CTD | PMID:21441140 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CCL2 mRNA | CTD | PMID:19372248 PMID:21441140 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:11275 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CCL2 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:3645 | 6480464 | AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CCL2 mRNA] | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:3645 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CCL2 mRNA | CTD | PMID:19692669 PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:11275 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CCL2 mRNA | CTD | PMID:17320037 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:11275 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CCL2 mRNA | CTD | PMID:19933214 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:11275 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CCL2 mRNA | CTD | PMID:19372248 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:11275 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CCL2 mRNA | CTD | PMID:16054899 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:11275 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CCL2 mRNA | CTD | PMID:17320037 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:11275 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CCL2 mRNA | CTD | PMID:18606429 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:11275 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CCL2 mRNA | CTD | PMID:15591033 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:3645 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CCL2 mRNA | CTD | PMID:19692669 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:11275 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CCL2 mRNA | CTD | PMID:19372248 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:11275 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CCL2 mRNA | CTD | PMID:16054899 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:11275 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CCL2 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CCL2 mRNA | CTD | PMID:19372248 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | RGD:11275 | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of CCL2 mRNA | CTD | PMID:17982090 |
| 2,4,6-trinitrotoluene | affects expression | ISO | RGD:3645 | 6480464 | Trinitrotoluene affects the expression of CCL2 mRNA | CTD | PMID:21346803 |
| 2,4-D | increases expression | ISO | RGD:11275 | 6480464 | 2,4-Dichlorophenoxyacetic Acid results in increased expression of CCL2 protein | CTD | PMID:19467290 |
| 2,6-di-tert-butyl-4-methylphenol | increases secretion | ISO | RGD:11275 | 6480464 | Butylated Hydroxytoluene results in increased secretion of CCL2 protein | CTD | PMID:16443645 |
| 2,6-di-tert-butyl-4-methylphenol | multiple interactions | ISO | RGD:11275 | 6480464 | Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of CCL2 protein] | CTD | PMID:16822543 |
| 2,6-di-tert-butyl-4-methylphenol | increases expression | ISO | RGD:11275 | 6480464 | Butylated Hydroxytoluene results in increased expression of CCL2 protein | CTD | PMID:16443645 |
| 2-amino-2-deoxy-D-galactopyranose | multiple interactions | ISO | RGD:11275 | 6480464 | [Galactosamine co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA; more ... | CTD | PMID:21146893 |
| 2-amino-2-deoxy-D-glucopyranose | increases expression | ISO | RGD:3645 | 6480464 | Glucosamine results in increased expression of CCL2 mRNA | CTD | PMID:17109745 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | EXP | | 6480464 | Glucosamine inhibits the reaction [TNF results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:19020780 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | EXP | | 6480464 | Glucosamine analog inhibits the reaction [IL1B results in increased secretion of CCL2 protein] | CTD | PMID:18080321 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | EXP | | 6480464 | Alloxan inhibits the reaction [Glucosamine inhibits the reaction [CAP18 lipopolysaccharide-binding protein results in increased expression of CCL2 protein]]; more ... | CTD | PMID:18949387 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | RGD:3645 | 6480464 | IL1B promotes the reaction [Glucosamine results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:17109745 |
| 2-arachidonoylglycerol | increases expression | EXP | | 6480464 | 2-arachidonylglycerol results in increased expression of CCL2 protein | CTD | PMID:15115777 |
| 2-butoxyethanol | increases expression | ISO | RGD:11275 | 6480464 | n-butoxyethanol results in increased expression of CCL2 mRNA | CTD | PMID:19812364 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | multiple interactions | ISO | RGD:3645 | 6480464 | fluvastatin inhibits the reaction [Puromycin Aminonucleoside results in increased expression of CCL2 mRNA] | CTD | PMID:16452496 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | multiple interactions | ISO | RGD:3645 | 6480464 | Tretinoin inhibits the reaction [Puromycin Aminonucleoside results in increased expression of CCL2 protein] | CTD | PMID:12813006 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases expression | ISO | RGD:3645 | 6480464 | Puromycin Aminonucleoside results in increased expression of CCL2 protein | CTD | PMID:12813006 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | affects expression | ISO | RGD:3645 | 6480464 | Puromycin Aminonucleoside affects the expression of CCL2 mRNA | CTD | PMID:10867541 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases expression | ISO | RGD:3645 | 6480464 | Puromycin Aminonucleoside results in increased expression of CCL2 mRNA | CTD | PMID:16452496 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | RGD:11275 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 protein; more ... | CTD | PMID:19265715 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | RGD:3645 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA | CTD | PMID:19692669 PMID:20959002 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | RGD:3645 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA | CTD | PMID:19692669 |
| 3,3',4,4',5-pentachlorobiphenyl | multiple interactions | ISO | RGD:11275 | 6480464 | CAV1 affects the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:19265715 |
| 3,3',4,4'-tetrachlorobiphenyl | increases expression | ISO | RGD:11275 | 6480464 | 3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA | CTD | PMID:21925196 |
| 3-chloropropane-1,2-diol | decreases expression | ISO | RGD:3645 | 6480464 | alpha-Chlorohydrin results in decreased expression of CCL2 mRNA | CTD | PMID:20409345 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of CCL2 mRNA | CTD | PMID:16997883 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:11275 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA; more ... | CTD | PMID:16054899 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:11275 | 6480464 | Benzo(a)pyrene inhibits the reaction [1-Methyl-3-isobutylxanthine results in decreased expression of CCL2 mRNA]; more ... | CTD | PMID:19141685 |
| 3-isobutyl-1-methyl-7H-xanthine | decreases expression | ISO | RGD:11275 | 6480464 | 1-Methyl-3-isobutylxanthine results in decreased expression of CCL2 mRNA | CTD | PMID:19141685 |
| 3-methylcholanthrene | increases expression | ISO | RGD:11275 | 6480464 | Methylcholanthrene results in increased expression of CCL2 mRNA | CTD | PMID:20713471 |
| 3H-1,2-dithiole-3-thione | increases expression | ISO | RGD:3645 | 6480464 | 1,2-dithiol-3-thione results in increased expression of CCL2 mRNA | CTD | PMID:19162173 |
| 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:11275 | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of CCL2 mRNA | CTD | PMID:18648102 |
| 4-(ethoxymethylene)-2-phenyloxazol-5-one | decreases expression | EXP | | 6480464 | Oxazolone results in decreased expression of CCL2 mRNA | CTD | PMID:17374397 |
| 4-(ethoxymethylene)-2-phenyloxazol-5-one | increases expression | ISO | RGD:11275 | 6480464 | Oxazolone results in increased expression of CCL2 mRNA | CTD | PMID:19647056 |
| 4-(ethoxymethylene)-2-phenyloxazol-5-one | increases expression | EXP | | 6480464 | Oxazolone results in increased expression of CCL2 mRNA | CTD | PMID:15585374 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | decreases expression | EXP | | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CCL2 protein | CTD | PMID:15762874 |
| 4-hydroxynon-2-enal | decreases expression | ISO | RGD:11275 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of CCL2 mRNA | CTD | PMID:19191707 |
| 4-nitroquinoline N-oxide | increases expression | ISO | RGD:11275 | 6480464 | 4-Nitroquinoline-1-oxide results in increased expression of CCL2 mRNA | CTD | PMID:22561872 |
| 7,9-dihydro-1H-purine-2,6,8(3H)-trione | multiple interactions | EXP | | 6480464 | Allopurinol inhibits the reaction [[Fructose co-treated with Uric Acid] results in increased secretion of CCL2 protein] | CTD | PMID:19158351 |
| 7,9-dihydro-1H-purine-2,6,8(3H)-trione | increases expression | ISO | RGD:3645 | 6480464 | Uric Acid results in increased expression of CCL2 protein | CTD | PMID:16113518 |
| 7,9-dihydro-1H-purine-2,6,8(3H)-trione | multiple interactions | ISO | RGD:3645 | 6480464 | Probenecid inhibits the reaction [Uric Acid results in increased expression of CCL2 protein] | CTD | PMID:16113518 |
| 7,9-dihydro-1H-purine-2,6,8(3H)-trione | increases secretion | EXP | | 6480464 | Uric Acid results in increased secretion of CCL2 protein | CTD | PMID:19158351 |
| 8-bromo-3',5'-cyclic AMP | multiple interactions | EXP | | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [TNF protein results in increased secretion of CCL2 protein]]; more ... | CTD | PMID:11230753 |
| 8-bromo-3',5'-cyclic AMP | increases expression | ISO | RGD:3645 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CCL2 protein | CTD | PMID:20940016 |
| 8-bromo-3',5'-cyclic AMP | multiple interactions | EXP | | 6480464 | [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of CCL2 mRNA | CTD | PMID:16997883 |
| 9-cis-retinoic acid | multiple interactions | EXP | | 6480464 | [22-hydroxycholesterol co-treated with alitretinoin] inhibits the reaction [IFNG promotes the reaction [STAT1 protein binds to CCL2 promoter]] | CTD | PMID:21268089 |
| acarbose | multiple interactions | ISO | RGD:3645 | 6480464 | Acarbose inhibits the reaction [Fructose results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:17133782 |
| acetaldehyde | increases expression | EXP | | 6480464 | Acetaldehyde results in increased expression of CCL2 mRNA | CTD | PMID:17050345 |
| acetylsalicylic acid | multiple interactions | EXP | | 6480464 | Aspirin inhibits the reaction [Glucose results in increased expression of CCL2 protein]; more ... | CTD | PMID:16600694 |
| acetylsalicylic acid | multiple interactions | EXP | | 6480464 | Aspirin inhibits the reaction [TNF results in increased secretion of CCL2 protein]; more ... | CTD | PMID:15136050 |
| acrolein | increases expression | ISO | RGD:11275 | 6480464 | Acrolein results in increased expression of CCL2 mRNA | CTD | PMID:17950725 |
| acrolein | multiple interactions | ISO | RGD:11275 | 6480464 | CD8A protein promotes the reaction [Acrolein results in increased expression of CCL2 mRNA] | CTD | PMID:17950725 |
| acrylonitrile | decreases expression | EXP | | 6480464 | Acrylonitrile results in decreased expression of CCL2 mRNA | CTD | PMID:16173056 |
| actinomycin D | multiple interactions | EXP | | 6480464 | Dactinomycin inhibits the reaction [AGT protein results in increased expression of CCL2 mRNA] | CTD | PMID:16705055 |
| actinomycin D | multiple interactions | EXP | | 6480464 | Dactinomycin inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | CTD | PMID:15531761 |
| aflatoxin B1 | increases expression | ISO | RGD:11275 | 6480464 | Aflatoxin B1 results in increased expression of CCL2 mRNA | CTD | PMID:19770486 |
| albendazole | increases expression | EXP | | 6480464 | Albendazole results in increased expression of CCL2 protein | CTD | PMID:20116850 |
| alclometasone dipropionate | decreases expression | EXP | | 6480464 | alclometasone dipropionate results in decreased expression of CCL2 protein | CTD | PMID:20116850 |
| aldehydo-D-glucosamine | multiple interactions | ISO | RGD:3645 | 6480464 | IL1B promotes the reaction [Glucosamine results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:17109745 |
| aldehydo-D-glucosamine | increases expression | ISO | RGD:3645 | 6480464 | Glucosamine results in increased expression of CCL2 mRNA | CTD | PMID:17109745 |
| aldehydo-D-glucosamine | multiple interactions | EXP | | 6480464 | Glucosamine inhibits the reaction [TNF results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:19020780 |
| aldehydo-D-glucosamine | multiple interactions | EXP | | 6480464 | Glucosamine analog inhibits the reaction [IL1B results in increased secretion of CCL2 protein] | CTD | PMID:18080321 |
| aldehydo-D-glucosamine | multiple interactions | EXP | | 6480464 | Alloxan inhibits the reaction [Glucosamine inhibits the reaction [CAP18 lipopolysaccharide-binding protein results in increased expression of CCL2 protein]]; more ... | CTD | PMID:18949387 |
| alexidine | decreases expression | EXP | | 6480464 | alexidine results in decreased expression of CCL2 protein | CTD | PMID:20116850 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [arsenic trioxide co-treated with Tretinoin] results in increased expression of CCL2 mRNA; more ... | CTD | PMID:19828696 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CCL2 mRNA | CTD | PMID:15894607 more ... |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with arsenic trioxide] results in increased expression of CCL2 mRNA | CTD | PMID:15894607 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CCL2 protein | CTD | PMID:17118196 PMID:19828696 |
| all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of CCL2 protein | CTD | PMID:12431242 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CCL2 mRNA | CTD | PMID:17218384 PMID:19828696 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:3645 | 6480464 | Tretinoin results in decreased expression of CCL2 mRNA | CTD | PMID:12969142 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:3645 | 6480464 | Tretinoin inhibits the reaction [Puromycin Aminonucleoside results in increased expression of CCL2 protein] | CTD | PMID:12813006 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CCL2 protein | CTD | PMID:19828696 PMID:17118196 |
| all-trans-retinoic acid | decreases secretion | ISO | RGD:11275 | 6480464 | Tretinoin results in decreased secretion of CCL2 protein | CTD | PMID:16096774 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:11275 | 6480464 | Tretinoin results in decreased expression of CCL2 mRNA | CTD | PMID:16412693 |
| all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of CCL2 mRNA | CTD | PMID:16054129 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CCL2 mRNA | CTD | PMID:19828696 PMID:17218384 |
| all-trans-retinol | decreases expression | EXP | | 6480464 | Vitamin A results in decreased expression of CCL2 protein | CTD | PMID:16988133 |
| allopurinol | multiple interactions | EXP | | 6480464 | Allopurinol inhibits the reaction [[Fructose co-treated with Uric Acid] results in increased secretion of CCL2 protein]; more ... | CTD | PMID:19158351 |
| allopurinol | multiple interactions | ISO | RGD:3645 | 6480464 | Allopurinol inhibits the reaction [sodium arsenite results in increased expression of CCL2 mRNA] | CTD | PMID:15689417 |
| allyl alcohol | increases expression | EXP | | 6480464 | allyl alcohol results in increased expression of CCL2 mRNA | CTD | PMID:21907259 |
| alpha-hexylcinnamaldehyde | increases secretion | ISO | RGD:11275 | 6480464 | hexyl cinnamic aldehyde results in increased secretion of CCL2 protein | CTD | PMID:22245253 |
| aluminium hydroxide | increases secretion | EXP | | 6480464 | Aluminum Hydroxide results in increased secretion of CCL2 protein | CTD | PMID:18390722 |
| amiloride | multiple interactions | EXP | | 6480464 | Amiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein] | CTD | PMID:12107048 |
| amiloride | multiple interactions | ISO | RGD:3645 | 6480464 | Amiloride inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; more ... | CTD | PMID:11340305 |
| amiloride | decreases expression | ISO | RGD:3645 | 6480464 | Amiloride results in decreased expression of CCL2 mRNA; more ... | CTD | PMID:11340305 |
| amiodarone | multiple interactions | EXP | | 6480464 | Amiodarone inhibits the reaction [CRP protein results in increased expression of CCL2 protein] | CTD | PMID:19225199 |
| amlodipine | decreases expression | ISO | RGD:3645 | 6480464 | Amlodipine results in decreased expression of CCL2 mRNA | CTD | PMID:16392774 |
| ammonium chloride | affects expression | ISO | RGD:3645 | 6480464 | Ammonium Chloride affects the expression of CCL2 mRNA | CTD | PMID:16483693 |
| amprenavir | increases expression | EXP | | 6480464 | amprenavir results in increased expression of CCL2 protein | CTD | PMID:17668557 |
| andrographolide | multiple interactions | ISO | RGD:11275 | 6480464 | [andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CCL2 mRNA | CTD | PMID:19737545 |
| antimycin A | decreases expression | EXP | | 6480464 | Antimycin A results in decreased expression of CCL2 protein | CTD | PMID:20116850 |
| apocynin | multiple interactions | EXP | | 6480464 | acetovanillone inhibits the reaction [Fructose results in increased secretion of CCL2 protein] | CTD | PMID:19158351 |
| apocynin | multiple interactions | EXP | | 6480464 | acetovanillone inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:22414048 |
| apocynin | multiple interactions | EXP | | 6480464 | acetovanillone inhibits the reaction [Homocysteine results in increased expression of CCL2 mRNA] | CTD | PMID:16845898 |
| arsenic atom | increases expression | EXP | | 6480464 | Arsenic results in increased expression of CCL2 mRNA | CTD | PMID:12928151 |
| arsenic atom | increases response to substance | EXP | | 6480464 | CCL2 polymorphism results in increased susceptibility to Arsenic | CTD | PMID:18022660 |
| arsenite(3-) | multiple interactions | EXP | | 6480464 | caffeic acid phenethyl ester inhibits the reaction [arsenite results in decreased expression of CCL2 mRNA] | CTD | PMID:16085347 |
| arsenite(3-) | decreases expression | EXP | | 6480464 | arsenite results in decreased expression of CCL2 mRNA | CTD | PMID:16085347 |
| asbestos | increases expression | ISO | RGD:11275 | 6480464 | Asbestos results in increased expression of CCL2 protein | CTD | PMID:18795166 |
| asbestos | increases expression | EXP | | 6480464 | Asbestos results in increased expression of CCL2 mRNA | CTD | PMID:22398240 |
| atazanavir | increases expression | EXP | | 6480464 | atazanavir results in increased expression of CCL2 protein | CTD | PMID:17668557 |
| azithromycin | decreases expression | ISO | RGD:11275 | 6480464 | Azithromycin results in decreased expression of CCL2 protein | CTD | PMID:20231397 |
| bathocuproine disulfonic acid | multiple interactions | EXP | | 6480464 | bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]] | CTD | PMID:11006087 |
| beclomethasone | decreases expression | EXP | | 6480464 | Beclomethasone results in decreased expression of CCL2 protein | CTD | PMID:20116850 |
| benazepril | multiple interactions | ISO | RGD:3645 | 6480464 | benazepril inhibits the reaction [Ethylene Glycol results in increased expression of CCL2 protein] | CTD | PMID:16284884 |
| benazepril | multiple interactions | ISO | RGD:3645 | 6480464 | benazepril inhibits the reaction [Estrogens deficiency results in increased expression of CCL2 protein] | CTD | PMID:19553526 |
| benzene | increases expression | ISO | RGD:3645 | 6480464 | Benzene results in increased expression of CCL2 protein | CTD | PMID:15902427 |
| benzene | increases expression | EXP | | 6480464 | Benzene results in increased expression of CCL2 mRNA | CTD | PMID:21843810 |
| benzene-1,2,4-triol | affects expression | EXP | | 6480464 | hydroxyhydroquinone affects the expression of CCL2 protein | CTD | PMID:17572062 |
| benzo[a]pyrene | increases expression | ISO | RGD:11275 | 6480464 | Benzo(a)pyrene results in increased expression of CCL2 mRNA | CTD | PMID:20713471 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CCL2 mRNA | CTD | PMID:22316170 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:11275 | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein binds to CCL2 promoter] | CTD | PMID:19654925 |
| benzo[a]pyrene | decreases expression | ISO | RGD:11275 | 6480464 | Benzo(a)pyrene results in decreased expression of CCL2 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:11275 | 6480464 | Benzo(a)pyrene inhibits the reaction [1-Methyl-3-isobutylxanthine results in decreased expression of CCL2 mRNA] | CTD | PMID:19141685 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CCL2 mRNA | CTD | PMID:20064835 |
| berberine | multiple interactions | EXP | | 6480464 | Berberine inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein]; more ... | CTD | PMID:16391493 |
| beta-D-glucosamine | increases expression | ISO | RGD:3645 | 6480464 | Glucosamine results in increased expression of CCL2 mRNA | CTD | PMID:17109745 |
| beta-D-glucosamine | multiple interactions | EXP | | 6480464 | Glucosamine inhibits the reaction [TNF results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:19020780 |
| beta-D-glucosamine | multiple interactions | EXP | | 6480464 | Glucosamine analog inhibits the reaction [IL1B results in increased secretion of CCL2 protein] | CTD | PMID:18080321 |
| beta-D-glucosamine | multiple interactions | EXP | | 6480464 | Alloxan inhibits the reaction [Glucosamine inhibits the reaction [CAP18 lipopolysaccharide-binding protein results in increased expression of CCL2 protein]]; more ... | CTD | PMID:18949387 |
| beta-D-glucosamine | multiple interactions | ISO | RGD:3645 | 6480464 | IL1B promotes the reaction [Glucosamine results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:17109745 |
| betamethasone | decreases expression | EXP | | 6480464 | Betamethasone results in decreased expression of CCL2 protein | CTD | PMID:20116850 |
| bezafibrate | multiple interactions | ISO | RGD:11275 | 6480464 | Bezafibrate inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of CCL2 mRNA] | CTD | PMID:18513333 |
| bezafibrate | decreases expression | ISO | RGD:11275 | 6480464 | Bezafibrate results in decreased expression of CCL2 mRNA | CTD | PMID:16574099 |
| bicalutamide | multiple interactions | EXP | | 6480464 | bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]]; more ... | CTD | PMID:16317058 |
| bis(2-chloroethyl) sulfide | increases expression | EXP | | 6480464 | Mustard Gas results in increased expression of CCL2 protein | CTD | PMID:17720292 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:11275 | 6480464 | Mustard Gas results in increased expression of CCL2 mRNA | CTD | PMID:18955075 |
| bisoprolol | decreases expression | EXP | | 6480464 | Bisoprolol results in decreased expression of CCL2 protein | CTD | PMID:19840533 |
| bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of CCL2 mRNA | CTD | PMID:19490990 |
| bisphenol A | multiple interactions | EXP | | 6480464 | bisphenol A inhibits the reaction [IL1A protein promotes the reaction [[RELA protein co-treated with NFKB1 protein] binds to CCL2 promoter]]; more ... | CTD | PMID:10614622 |
| bleomycin A2 | increases expression | ISO | RGD:11275 | 6480464 | Bleomycin results in increased expression of CCL2 mRNA | CTD | PMID:15541506 more ... |
| bleomycin A2 | increases expression | ISO | RGD:11275 | 6480464 | Bleomycin results in increased expression of CCL2 mRNA | CTD | PMID:15541506 more ... |
| bleomycin A2 | increases expression | ISO | RGD:11275 | 6480464 | Bleomycin results in increased expression of CCL2 protein | CTD | PMID:15541506 PMID:19147827 |
| bleomycin A2 | increases expression | ISO | RGD:11275 | 6480464 | Bleomycin results in increased expression of CCL2 mRNA | CTD | PMID:16314464 more ... |
| bleomycin A2 | multiple interactions | ISO | RGD:11275 | 6480464 | rosiglitazone inhibits the reaction [Bleomycin results in increased expression of CCL2 protein] | CTD | PMID:19147827 |
| bleomycin A2 | increases expression | ISO | RGD:11275 | 6480464 | Bleomycin results in increased expression of CCL2 protein | CTD | PMID:19147827 PMID:15541506 |
| bleomycin A2 | increases expression | ISO | RGD:11275 | 6480464 | Bleomycin results in increased expression of CCL2 mRNA | CTD | PMID:17177178 more ... |
| bleomycin A2 | multiple interactions | ISO | RGD:11275 | 6480464 | CEBPB protein affects the reaction [Bleomycin results in increased expression of CCL2 mRNA] | CTD | PMID:17177178 |
| bleomycin A2 | multiple interactions | ISO | RGD:11275 | 6480464 | tetrathiomolybdate inhibits the reaction [Bleomycin results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:15541506 |
| bleomycin A2 | multiple interactions | ISO | RGD:11275 | 6480464 | CCL11 protein promotes the reaction [Bleomycin results in increased expression of CCL2 mRNA] | CTD | PMID:16314464 |
| bleomycin A2 | increases expression | ISO | RGD:11275 | 6480464 | Bleomycin results in increased expression of CCL2 protein | CTD | PMID:15541506 |
| bleomycin A2 | increases expression | ISO | RGD:11275 | 6480464 | Bleomycin results in increased expression of CCL2 mRNA | CTD | PMID:16314464 more ... |
| budesonide | decreases expression | EXP | | 6480464 | Budesonide results in decreased expression of CCL2 protein | CTD | PMID:20116850 |
| budesonide | multiple interactions | ISO | RGD:3645 | 6480464 | Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:15734790 |
| butyric acid | increases expression | EXP | | 6480464 | Butyric Acid results in increased expression of CCL2 mRNA | CTD | PMID:17928716 |
| C60 fullerene | increases expression | ISO | RGD:3645 | 6480464 | fullerene C60 results in increased expression of CCL2 mRNA | CTD | PMID:20471445 |
| cadmium atom | multiple interactions | EXP | | 6480464 | [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of CCL2 mRNA | CTD | PMID:21481475 |
| cadmium dichloride | increases methylation | ISO | RGD:3645 | 6480464 | Cadmium Chloride results in increased methylation of CCL2 promoter | CTD | PMID:22457795 |
| cadmium selenide | multiple interactions | EXP | | 6480464 | [cadmium selenide co-treated with zinc sulfide] results in decreased expression of CCL2 mRNA | CTD | PMID:22342292 |
| calcitriol | decreases expression | EXP | | 6480464 | Calcitriol results in decreased expression of CCL2 protein | CTD | PMID:18379402 |
| calcium atom | multiple interactions | EXP | | 6480464 | Piperidines analog inhibits the reaction [CCL2 protein results in increased uptake of Calcium] | CTD | PMID:10843593 |
| calcium atom | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [CCL2 protein affects the localization of Calcium] | CTD | PMID:16212921 |
| calcium atom | increases abundance | EXP | | 6480464 | CCL2 protein results in increased abundance of Calcium | CTD | PMID:16771778 |
| calcium atom | increases uptake | EXP | | 6480464 | CCL2 protein results in increased uptake of Calcium | CTD | PMID:10984371 |
| calcium atom | multiple interactions | EXP | | 6480464 | montelukast inhibits the reaction [CCL2 protein results in increased abundance of Calcium] | CTD | PMID:16771778 |
| calcium dichloride | increases phosphorylation | ISO | RGD:11275 | 6480464 | Calcium Chloride results in increased phosphorylation of CCL2 protein | CTD | PMID:21530968 |
| calcium dichloride | multiple interactions | ISO | RGD:11275 | 6480464 | resveratrol inhibits the reaction [Calcium Chloride results in increased phosphorylation of CCL2 protein]; more ... | CTD | PMID:21530968 |
| calcium dichloride | increases expression | ISO | RGD:11275 | 6480464 | Calcium Chloride results in increased expression of CCL2 mRNA | CTD | PMID:21530968 |
| calcium(0) | multiple interactions | EXP | | 6480464 | Piperidines analog inhibits the reaction [CCL2 protein results in increased uptake of Calcium] | CTD | PMID:10843593 |
| calcium(0) | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [CCL2 protein affects the localization of Calcium] | CTD | PMID:16212921 |
| calcium(0) | increases abundance | EXP | | 6480464 | CCL2 protein results in increased abundance of Calcium | CTD | PMID:16771778 |
| calcium(0) | increases uptake | EXP | | 6480464 | CCL2 protein results in increased uptake of Calcium | CTD | PMID:10984371 |
| calcium(0) | multiple interactions | EXP | | 6480464 | montelukast inhibits the reaction [CCL2 protein results in increased abundance of Calcium] | CTD | PMID:16771778 |
| camptothecin | decreases expression | EXP | | 6480464 | Camptothecin results in decreased expression of CCL2 protein | CTD | PMID:20116850 |
| capsaicin | decreases expression | ISO | RGD:11275 | 6480464 | Capsaicin results in decreased expression of CCL2 protein | CTD | PMID:19798065 |
| capsaicin | decreases expression | ISO | RGD:11275 | 6480464 | Capsaicin results in decreased expression of CCL2 mRNA | CTD | PMID:17719033 PMID:19798065 |
| capsaicin | decreases secretion | ISO | RGD:11275 | 6480464 | Capsaicin results in decreased secretion of CCL2 protein | CTD | PMID:17719033 PMID:19798065 |
| capsaicin | decreases secretion | ISO | RGD:11275 | 6480464 | Capsaicin results in decreased secretion of CCL2 protein | CTD | PMID:17719033 |
| capsaicin | multiple interactions | ISO | RGD:11275 | 6480464 | troglitazone promotes the reaction [Capsaicin results in decreased secretion of CCL2 protein] | CTD | PMID:17719033 |
| capsaicin | decreases expression | ISO | RGD:11275 | 6480464 | Capsaicin results in decreased expression of CCL2 mRNA | CTD | PMID:17719033 |
| capsaicin | multiple interactions | ISO | RGD:3645 | 6480464 | Naproxen inhibits the reaction [Capsaicin results in increased expression of CCL2 protein]; more ... | CTD | PMID:22150557 |
| capsaicin | decreases secretion | ISO | RGD:11275 | 6480464 | Capsaicin results in decreased secretion of CCL2 protein | CTD | PMID:19798065 PMID:17719033 |
| capsaicin | decreases expression | ISO | RGD:11275 | 6480464 | Capsaicin results in decreased expression of CCL2 mRNA | CTD | PMID:19798065 PMID:17719033 |
| capsaicin | increases expression | ISO | RGD:3645 | 6480464 | Capsaicin results in increased expression of CCL2 protein | CTD | PMID:22150557 |
| capsaicin | increases expression | ISO | RGD:3645 | 6480464 | Capsaicin results in increased expression of CCL2 mRNA | CTD | PMID:20349343 |
| capsaicin | multiple interactions | ISO | RGD:11275 | 6480464 | capsazepine inhibits the reaction [Capsaicin results in decreased secretion of CCL2 protein] | CTD | PMID:19798065 |
| carbonyl sulfide | increases expression | ISO | RGD:3645 | 6480464 | carbonyl sulfide results in increased expression of CCL2 mRNA | CTD | PMID:19395590 |
| carmustine | affects activity | EXP | | 6480464 | Carmustine affects the activity of CCL2 protein | CTD | PMID:17522861 |
| carmustine | affects response to substance | EXP | | 6480464 | CCL2 mRNA affects the susceptibility to Carmustine | CTD | PMID:16365179 |
| carmustine | decreases expression | EXP | | 6480464 | Carmustine results in decreased expression of CCL2 protein | CTD | PMID:17522861 |
| carmustine | increases expression | EXP | | 6480464 | Carmustine results in increased expression of CCL2 mRNA | CTD | PMID:15980968 |
| carnosine | multiple interactions | ISO | RGD:11275 | 6480464 | Carnosine inhibits the reaction [Acetaminophen results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:19799668 |
| carrageenan | increases expression | ISO | RGD:11275 | 6480464 | Carrageenan results in increased expression of CCL2 protein | CTD | PMID:12444156 |
| carrageenan | increases expression | ISO | RGD:11275 | 6480464 | Carrageenan results in increased expression of CCL2 protein | CTD | PMID:12444156 PMID:20383154 |
| carrageenan | multiple interactions | ISO | RGD:11275 | 6480464 | 5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid inhibits the reaction [Carrageenan results in increased expression of CCL2 protein] | CTD | PMID:20383154 |
| carrageenan | increases expression | ISO | RGD:11275 | 6480464 | Carrageenan results in increased expression of CCL2 protein | CTD | PMID:20383154 PMID:12444156 |
| catechol | increases expression | EXP | | 6480464 | catechol results in increased expression of CCL2 protein | CTD | PMID:17572062 |
| celecoxib | decreases expression | ISO | RGD:11275 | 6480464 | celecoxib results in decreased expression of CCL2 mRNA | CTD | PMID:12902868 |
| celecoxib | multiple interactions | ISO | RGD:3645 | 6480464 | celecoxib inhibits the reaction [Dietary Fats results in increased expression of CCL2 protein]; more ... | CTD | PMID:20039930 |
| cephaeline | decreases expression | EXP | | 6480464 | cephaelin results in decreased expression of CCL2 protein | CTD | PMID:20116850 |
| ceruletide | multiple interactions | ISO | RGD:11275 | 6480464 | PPARG affects the reaction [Caerulein results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:17463185 |
| ceruletide | increases expression | ISO | RGD:11275 | 6480464 | Caerulein results in increased expression of CCL2 mRNA | CTD | PMID:17463185 PMID:21484880 |
| ceruletide | increases expression | ISO | RGD:11275 | 6480464 | Caerulein results in increased expression of CCL2 mRNA | CTD | PMID:17463185 |
| chenodeoxycholic acid | increases expression | ISO | RGD:11275 | 6480464 | Chenodeoxycholic Acid results in increased expression of CCL2 mRNA | CTD | PMID:21224055 |
| chenodeoxycholic acid | multiple interactions | ISO | RGD:11275 | 6480464 | EGR1 promotes the reaction [Chenodeoxycholic Acid results in increased expression of CCL2 mRNA] | CTD | PMID:21224055 |
| chlorobenzene | increases expression | EXP | | 6480464 | chlorobenzene results in increased expression of CCL2 protein | CTD | PMID:17993253 more ... |
| chlorobenzene | increases secretion | EXP | | 6480464 | chlorobenzene results in increased secretion of CCL2 protein | CTD | PMID:19800902 |
| chlorobenzene | multiple interactions | EXP | | 6480464 | bucillamine inhibits the reaction [chlorobenzene results in increased secretion of CCL2 protein]; more ... | CTD | PMID:19800902 |
| chlorobenzene | increases expression | EXP | | 6480464 | chlorobenzene results in increased expression of CCL2 protein | CTD | PMID:18514500 more ... |
| chlorobenzene | increases expression | EXP | | 6480464 | chlorobenzene results in increased expression of CCL2 protein | CTD | PMID:18514500 more ... |
| chlorobenzene | multiple interactions | EXP | | 6480464 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [chlorobenzene results in increased expression of CCL2 protein]; more ... | CTD | PMID:18645721 |
| chlorobenzene | multiple interactions | EXP | | 6480464 | CCL2 protein promotes the reaction [chlorobenzene results in increased expression of IL13 protein] | CTD | PMID:18514500 |
| chlorobenzene | increases expression | EXP | | 6480464 | chlorobenzene results in increased expression of CCL2 protein | CTD | PMID:18645721 more ... |
| chloroform | increases expression | EXP | | 6480464 | Chloroform results in increased expression of CCL2 mRNA | CTD | PMID:21907259 |
| chloroquine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Chloroquine results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:15139008 |
| chloroquine | increases expression | EXP | | 6480464 | Chloroquine results in increased expression of CCL2 mRNA | CTD | PMID:15139008 |
| cholesterol | multiple interactions | ISO | RGD:11275 | 6480464 | Cholesterol inhibits the reaction [irbesartan results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:19028402 |
| cholesterol | multiple interactions | ISO | RGD:11275 | 6480464 | [Cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of CCL2 mRNA | CTD | PMID:22129739 |
| cholesterol | increases expression | ISO | RGD:11275 | 6480464 | Cholesterol results in increased expression of CCL2 protein; more ... | CTD | PMID:19028402 |
| choline | affects expression | EXP | | 6480464 | Choline affects the expression of CCL2 mRNA | CTD | PMID:17616785 |
| choline | multiple interactions | ISO | RGD:11275 | 6480464 | CCL2 protein inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of COL1A1 mRNA]; more ... | CTD | PMID:20697377 |
| choline | multiple interactions | ISO | RGD:11275 | 6480464 | [Methionine deficiency co-treated with Choline deficiency] results in increased expression of CCL2 mRNA; more ... | CTD | PMID:23038002 |
| choline | multiple interactions | ISO | RGD:11275 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CCL2 mRNA | CTD | PMID:20938992 |
| choline | multiple interactions | ISO | RGD:11275 | 6480464 | Bezafibrate inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of CCL2 mRNA] | CTD | PMID:18513333 |
| chondroitin sulfate | affects binding | EXP | | 6480464 | Chondroitin Sulfates binds to CCL2 protein | CTD | PMID:16385517 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:11275 | 6480464 | Ciguatoxins affects the expression of CCL2 mRNA | CTD | PMID:18353800 |
| cilostazol | multiple interactions | EXP | | 6480464 | cilostazol inhibits the reaction [TNF protein results in increased expression of CCL2]; more ... | CTD | PMID:19967051 |
| cimetidine | multiple interactions | EXP | | 6480464 | Cimetidine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein] | CTD | PMID:12107048 |
| cis-caffeic acid | multiple interactions | ISO | RGD:11275 | 6480464 | [resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of CCL2 mRNA | CTD | PMID:16806235 |
| cisplatin | increases expression | ISO | RGD:11275 | 6480464 | Cisplatin results in increased expression of CCL2 mRNA | CTD | PMID:15814532 more ... |
| cisplatin | increases expression | ISO | RGD:11275 | 6480464 | Cisplatin results in increased expression of CCL2 mRNA | CTD | PMID:20702592 more ... |
| cisplatin | increases expression | ISO | RGD:11275 | 6480464 | Cisplatin results in increased expression of CCL2 mRNA | CTD | PMID:15701814 more ... |
| cisplatin | increases expression | ISO | RGD:11275 | 6480464 | Cisplatin results in increased expression of CCL2 protein | CTD | PMID:20844023 |
| cisplatin | increases expression | ISO | RGD:11275 | 6480464 | Cisplatin results in increased expression of CCL2 mRNA | CTD | PMID:15814532 more ... |
| cisplatin | decreases expression | ISO | RGD:3645 | 6480464 | Cisplatin results in decreased expression of CCL2 mRNA | CTD | PMID:22023808 |
| cisplatin | multiple interactions | ISO | RGD:11275 | 6480464 | TIMD2 promotes the reaction [Cisplatin results in increased expression of CCL2 mRNA] | CTD | PMID:20702592 |
| cisplatin | multiple interactions | ISO | RGD:11275 | 6480464 | pirinixic acid inhibits the reaction [Cisplatin results in increased expression of CCL2 mRNA] | CTD | PMID:15814532 |
| clobenpropit | decreases expression | EXP | | 6480464 | clobenpropit results in decreased expression of CCL2 protein | CTD | PMID:17507084 |
| clofibrate | multiple interactions | EXP | | 6480464 | Clofibrate inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:16600694 |
| clofibrate | multiple interactions | EXP | | 6480464 | Clofibrate inhibits the reaction [Glucose results in increased expression of CCL2 protein]; more ... | CTD | PMID:16600694 PMID:19132243 |
| clofibrate | multiple interactions | EXP | | 6480464 | Clofibrate inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:19132243 PMID:16600694 |
| clonidine | multiple interactions | EXP | | 6480464 | Clonidine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein] | CTD | PMID:12107048 |
| clonidine (amino form) | multiple interactions | EXP | | 6480464 | Clonidine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein] | CTD | PMID:12107048 |
| clonidine (imino form) | multiple interactions | EXP | | 6480464 | Clonidine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein] | CTD | PMID:12107048 |
| cobalt atom | increases expression | EXP | | 6480464 | Cobalt results in increased expression of CCL2 mRNA | CTD | PMID:19132727 |
| cobalt atom | multiple interactions | EXP | | 6480464 | [tungsten carbide co-treated with Cobalt] results in decreased expression of CCL2 mRNA | CTD | PMID:18078969 |
| cobalt atom | increases secretion | EXP | | 6480464 | Cobalt results in increased secretion of CCL2 protein | CTD | PMID:19132727 |
| cobalt dichloride | multiple interactions | ISO | RGD:3645 | 6480464 | cobaltous chloride inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 protein] | CTD | PMID:19278353 |
| cobalt dichloride | multiple interactions | ISO | RGD:3645 | 6480464 | cobaltous chloride inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 protein] | CTD | PMID:18635243 PMID:19278353 |
| cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of CCL2 mRNA | CTD | PMID:14652683 PMID:19376846 |
| cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of CCL2 mRNA | CTD | PMID:19376846 PMID:14652683 |
| cocaine | increases secretion | EXP | | 6480464 | Cocaine results in increased secretion of CCL2 protein | CTD | PMID:10065903 |
| cocaine | increases expression | ISO | RGD:3645 | 6480464 | Cocaine results in increased expression of CCL2 protein | CTD | PMID:20354174 |
| cocaine | increases expression | ISO | RGD:11275 | 6480464 | Cocaine results in increased expression of CCL2 mRNA; more ... | CTD | PMID:20354174 |
| cocaine | multiple interactions | ISO | RGD:11275 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cocaine results in increased expression of CCL2 protein]; more ... | CTD | PMID:20354174 |
| codeine | increases secretion | EXP | | 6480464 | Codeine results in increased secretion of CCL2 protein | CTD | PMID:17441793 |
| copper atom | multiple interactions | ISO | RGD:3645 | 6480464 | [Copper co-treated with Diethylnitrosamine] results in increased expression of CCL2 mRNA; more ... | CTD | PMID:20302851 |
| copper atom | multiple interactions | ISO | RGD:3645 | 6480464 | [Copper deficiency co-treated with Fructose] results in increased expression of CCL2 protein | CTD | PMID:21781943 |
| copper atom | multiple interactions | EXP | | 6480464 | [Thiosemicarbazones binds to Copper] which results in increased expression of CCL2 protein | CTD | PMID:20931265 |
| copper(0) | multiple interactions | ISO | RGD:3645 | 6480464 | [Copper co-treated with Diethylnitrosamine] results in increased expression of CCL2 mRNA; more ... | CTD | PMID:20302851 |
| copper(0) | multiple interactions | ISO | RGD:3645 | 6480464 | [Copper deficiency co-treated with Fructose] results in increased expression of CCL2 protein | CTD | PMID:21781943 |
| copper(0) | multiple interactions | EXP | | 6480464 | [Thiosemicarbazones binds to Copper] which results in increased expression of CCL2 protein | CTD | PMID:20931265 |
| corticosterone | decreases expression | ISO | RGD:3645 | 6480464 | Corticosterone results in decreased expression of CCL2 mRNA | CTD | PMID:15755911 |
| cortisol | decreases expression | EXP | | 6480464 | Hydrocortisone results in decreased expression of CCL2 protein | CTD | PMID:20116850 |
| crocetin | multiple interactions | ISO | RGD:11275 | 6480464 | crocetin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | CTD | PMID:21925167 |
| crocidolite asbestos | decreases secretion | EXP | | 6480464 | Asbestos, Crocidolite results in decreased secretion of CCL2 protein | CTD | PMID:19041333 |
| crocidolite asbestos | increases secretion | ISO | RGD:3645 | 6480464 | Asbestos, Crocidolite results in increased secretion of CCL2 protein | CTD | PMID:10923243 |
| crocidolite asbestos | multiple interactions | ISO | RGD:3645 | 6480464 | IL1B protein promotes the reaction [Asbestos, Crocidolite results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:10923243 |
| crocidolite asbestos | increases expression | ISO | RGD:3645 | 6480464 | Asbestos, Crocidolite results in increased expression of CCL2 mRNA; more ... | CTD | PMID:10923243 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [TNF protein results in increased expression of CCL2 protein]; more ... | CTD | PMID:17666914 |
| curcumin | multiple interactions | ISO | RGD:3645 | 6480464 | Curcumin inhibits the reaction [Carbon Tetrachloride results in increased expression of CCL2 mRNA] | CTD | PMID:22683883 |
| curcumin | multiple interactions | ISO | RGD:11275 | 6480464 | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | CTD | PMID:20712904 |
| curcumin | decreases expression | ISO | RGD:3645 | 6480464 | Curcumin results in decreased expression of CCL2 mRNA | CTD | PMID:10925121 PMID:11053056 |
| curcumin | decreases expression | ISO | RGD:3645 | 6480464 | Curcumin results in decreased expression of CCL2 mRNA | CTD | PMID:11053056 PMID:10925121 |
| curcumin | decreases expression | ISO | RGD:11275 | 6480464 | Curcumin results in decreased expression of CCL2 mRNA; more ... | CTD | PMID:18403477 |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of CCL2 mRNA | CTD | PMID:17198877 |
| cycloheximide | multiple interactions | EXP | | 6480464 | TNF protein promotes the reaction [Cycloheximide results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:21146893 |
| cycloheximide | increases expression | EXP | | 6480464 | Cycloheximide results in increased expression of CCL2 mRNA | CTD | PMID:21146893 |
| cyclophosphamide | increases expression | ISO | RGD:11275 | 6480464 | Cyclophosphamide results in increased expression of CCL2 mRNA | CTD | PMID:21068404 |
| cyclophosphamide | decreases expression | ISO | RGD:3645 | 6480464 | Cyclophosphamide results in decreased expression of CCL2 protein | CTD | PMID:18848347 |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of CCL2 mRNA | CTD | PMID:22147139 |
| D-glucose | multiple interactions | EXP | | 6480464 | Aspirin inhibits the reaction [Glucose results in increased expression of CCL2 protein]; more ... | CTD | PMID:16600694 |
| D-glucose | multiple interactions | EXP | | 6480464 | CCL2 mRNA affects the reaction [Glucose results in increased expression of CTGF protein]; more ... | CTD | PMID:21367880 |
| D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL2 mRNA | CTD | PMID:16143069 more ... |
| D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL2 protein | CTD | PMID:16600694 more ... |
| D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL2 mRNA | CTD | PMID:16143069 more ... |
| D-glucose | multiple interactions | EXP | | 6480464 | SB 203580 inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | CTD | PMID:16143069 more ... |
| D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL2 mRNA | CTD | PMID:17655880 more ... |
| D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL2 protein | CTD | PMID:16600694 more ... |
| D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL2 mRNA | CTD | PMID:19225232 more ... |
| D-glucose | multiple interactions | EXP | | 6480464 | SB 203580 inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | CTD | PMID:16143069 more ... |
| D-glucose | multiple interactions | EXP | | 6480464 | PD 98059 inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:19132243 |
| D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL2 protein | CTD | PMID:19132243 more ... |
| D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL2 mRNA | CTD | PMID:19132243 more ... |
| D-glucose | multiple interactions | EXP | | 6480464 | Clofibrate inhibits the reaction [Glucose results in increased expression of CCL2 protein]; more ... | CTD | PMID:19132243 PMID:16600694 |
| D-glucose | multiple interactions | EXP | | 6480464 | Clofibrate inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:16600694 PMID:19132243 |
| D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL2 protein | CTD | PMID:16600694 PMID:17655880 |
| D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL2 mRNA | CTD | PMID:16143069 more ... |
| D-glucose | increases expression | ISO | RGD:11275 | 6480464 | Glucose results in increased expression of CCL2 mRNA | CTD | PMID:17178593 |
| D-glucose | multiple interactions | EXP | | 6480464 | SB 203580 inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | CTD | PMID:17655880 PMID:16143069 |
| D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL2 mRNA | CTD | PMID:16600694 more ... |
| D-glucose | increases expression | ISO | RGD:11275 | 6480464 | Glucose results in increased expression of CCL2 protein | CTD | PMID:17607302 |
| D-glucose | multiple interactions | EXP | | 6480464 | Selenium inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | CTD | PMID:16143069 |
| D-glucose | multiple interactions | EXP | | 6480464 | SB 203580 inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | CTD | PMID:16143069 PMID:17655880 |
| D-glucose | multiple interactions | EXP | | 6480464 | psicose inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:17655880 |
| D-glucose | increases secretion | EXP | | 6480464 | Glucose results in increased secretion of CCL2 protein | CTD | PMID:16600694 |
| D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL2 protein | CTD | PMID:17655880 PMID:16600694 |
| D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL2 mRNA | CTD | PMID:17655880 more ... |
| D-glucose | multiple interactions | EXP | | 6480464 | Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:19225232 |
| D-glucose | multiple interactions | EXP | | 6480464 | Glucose inhibits the reaction [Fructose results in increased secretion of CCL2 protein] | CTD | PMID:19158351 |
| dasatinib (anhydrous) | decreases expression | EXP | | 6480464 | dasatinib results in decreased expression of CCL2 protein | CTD | PMID:17962511 |
| daunorubicin | decreases expression | EXP | | 6480464 | Daunorubicin results in decreased expression of CCL2 protein | CTD | PMID:20116850 |
| deferiprone | multiple interactions | EXP | | 6480464 | deferiprone inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | CTD | PMID:14576080 |
| deoxycholic acid | increases expression | ISO | RGD:11275 | 6480464 | Deoxycholic Acid results in increased expression of CCL2 mRNA | CTD | PMID:21224055 |
| dexamethasone | multiple interactions | EXP | | 6480464 | 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [[Dexamethasone binds to NR3C1 protein] which results in decreased expression of CCL2 protein] | CTD | PMID:15187150 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of CCL2 mRNA | CTD | PMID:19853017 |
| dexamethasone | increases expression | ISO | RGD:11275 | 6480464 | Dexamethasone results in increased expression of CCL2 mRNA | CTD | PMID:21041162 |
| dexamethasone | increases expression | ISO | RGD:3645 | 6480464 | Dexamethasone results in increased expression of CCL2 mRNA | CTD | PMID:18234956 |
| dexamethasone | multiple interactions | ISO | RGD:11275 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA; more ... | CTD | PMID:16054899 |
| dexamethasone | multiple interactions | ISO | RGD:11275 | 6480464 | 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [[Dexamethasone binds to NR3C1 protein] which results in decreased expression of CCL2 protein] | CTD | PMID:15187150 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | CTD | PMID:19255438 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [Mitomycin results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:20002897 |
| dexamethasone | multiple interactions | EXP | | 6480464 | [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of CCL2 mRNA | CTD | PMID:16997883 |
| dextran sulfate | increases expression | ISO | RGD:11275 | 6480464 | Dextran Sulfate results in increased expression of CCL2 mRNA | CTD | PMID:20079348 |
| dextran sulfate | multiple interactions | ISO | RGD:11275 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Dextran Sulfate results in increased secretion of CCL2 protein] | CTD | PMID:21858153 |
| dextran sulfate | increases secretion | ISO | RGD:11275 | 6480464 | Dextran Sulfate results in increased secretion of CCL2 protein | CTD | PMID:21858153 |
| dextromethorphan | decreases expression | ISO | RGD:11275 | 6480464 | Dextromethorphan results in decreased expression of CCL2 protein | CTD | PMID:19189960 |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of CCL2 mRNA | CTD | PMID:19828696 more ... |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with arsenic trioxide] results in increased expression of CCL2 mRNA | CTD | PMID:15894607 |
| diarsenic trioxide | multiple interactions | ISO | RGD:11275 | 6480464 | Thioctic Acid inhibits the reaction [arsenic trioxide results in increased expression of CCL2 mRNA] | CTD | PMID:22488045 |
| diarsenic trioxide | increases expression | ISO | RGD:11275 | 6480464 | arsenic trioxide results in increased expression of CCL2 mRNA | CTD | PMID:22488045 |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of CCL2 mRNA | CTD | PMID:20458559 more ... |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of CCL2 mRNA | CTD | PMID:15761015 more ... |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of CCL2 mRNA | CTD | PMID:20458559 more ... |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of CCL2 mRNA | CTD | PMID:15761015 more ... |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of CCL2 protein | CTD | PMID:19828696 |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of CCL2 mRNA | CTD | PMID:20458559 more ... |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | [arsenic trioxide co-treated with Tretinoin] results in increased expression of CCL2 mRNA; more ... | CTD | PMID:19828696 |
| diazoxide | increases expression | ISO | RGD:11275 | 6480464 | Isoproterenol results in increased expression of CCL2 mRNA | CTD | PMID:21823215 |
| dibutyl phthalate | increases expression | ISO | RGD:3645 | 6480464 | Dibutyl Phthalate results in increased expression of CCL2 mRNA | CTD | PMID:21266533 |
| dichlorine | increases expression | ISO | RGD:11275 | 6480464 | Chlorine results in increased expression of CCL2 protein | CTD | PMID:23146759 |
| diclofenac | increases expression | ISO | RGD:11275 | 6480464 | Diclofenac results in increased expression of CCL2 mRNA | CTD | PMID:22285467 |
| dienogest | multiple interactions | EXP | | 6480464 | dienogest inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of CCL2 protein] | CTD | PMID:22014880 |
| diethylstilbestrol | increases expression | ISO | RGD:11275 | 6480464 | Diethylstilbestrol results in increased expression of CCL2 protein | CTD | PMID:15794588 |
| diethylstilbestrol | decreases expression | ISO | RGD:3645 | 6480464 | Diethylstilbestrol results in decreased expression of CCL2 mRNA | CTD | PMID:21658437 |
| digitoxigenin | decreases expression | EXP | | 6480464 | Digitoxigenin results in decreased expression of CCL2 protein | CTD | PMID:20116850 |
| digitoxin | multiple interactions | EXP | | 6480464 | Digitoxin inhibits the reaction [IL1B protein results in increased expression of CCL2 protein]; more ... | CTD | PMID:19446813 |
| digoxigenin | decreases expression | EXP | | 6480464 | Digoxigenin results in decreased expression of CCL2 protein | CTD | PMID:20116850 |
| digoxin | decreases expression | EXP | | 6480464 | Digoxin results in decreased expression of CCL2 protein | CTD | PMID:20116850 |
| dimethyl sulfoxide | multiple interactions | EXP | | 6480464 | Dimethyl Sulfoxide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; more ... | CTD | PMID:17529908 |
| dimethyl sulfoxide | multiple interactions | ISO | RGD:3645 | 6480464 | Dimethyl Sulfoxide inhibits the reaction [sodium arsenite results in increased expression of CCL2 mRNA] | CTD | PMID:15689417 |
| dimethyl sulfoxide | multiple interactions | EXP | | 6480464 | Dimethyl Sulfoxide inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein] | CTD | PMID:21878375 |
| dimethyl sulfoxide | decreases expression | ISO | RGD:3645 | 6480464 | Dimethyl Sulfoxide results in decreased expression of CCL2 mRNA | CTD | PMID:10925121 |
| dimethyl sulfoxide | multiple interactions | EXP | | 6480464 | Dimethyl Sulfoxide inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | CTD | PMID:14576080 |
| dioxygen | increases expression | ISO | RGD:11275 | 6480464 | Oxygen deficiency results in increased expression of CCL2 mRNA | CTD | PMID:18436887 |
| dioxygen | multiple interactions | ISO | RGD:3645 | 6480464 | deguelin promotes the reaction [Oxygen deficiency results in increased expression of CCL2 mRNA] | CTD | PMID:22745725 |
| dioxygen | increases expression | ISO | RGD:3645 | 6480464 | Oxygen deficiency results in increased expression of CCL2 mRNA | CTD | PMID:22745725 |
| dioxygen | increases expression | ISO | RGD:11275 | 6480464 | Oxygen deficiency results in increased expression of CCL2 mRNA | CTD | PMID:18436887 PMID:20412331 |
| dioxygen | multiple interactions | ISO | RGD:11275 | 6480464 | ARNT gene mutant form inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 mRNA] | CTD | PMID:20412331 |
| dioxygen | multiple interactions | ISO | RGD:3645 | 6480464 | Rolipram inhibits the reaction [Oxygen results in increased expression of CCL2 protein] | CTD | PMID:18941502 |
| dioxygen | increases expression | ISO | RGD:3645 | 6480464 | Oxygen results in increased expression of CCL2 mRNA; more ... | CTD | PMID:18941502 |
| dioxygen | increases expression | ISO | RGD:3645 | 6480464 | Oxygen deficiency results in increased expression of CCL2 protein | CTD | PMID:18635243 PMID:19278353 |
| dioxygen | multiple interactions | ISO | RGD:3645 | 6480464 | cobaltous chloride inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 protein] | CTD | PMID:18635243 PMID:19278353 |
| dioxygen | increases expression | ISO | RGD:3645 | 6480464 | Oxygen deficiency results in increased expression of CCL2 protein | CTD | PMID:19278353 |
| dioxygen | increases expression | ISO | RGD:11275 | 6480464 | Oxygen results in increased expression of CCL2 mRNA | CTD | PMID:10781441 |
| dioxygen | multiple interactions | ISO | RGD:3645 | 6480464 | cobaltous chloride inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 protein] | CTD | PMID:19278353 |
| dioxygen | decreases secretion | EXP | | 6480464 | Oxygen deficiency results in decreased secretion of CCL2 protein | CTD | PMID:14652683 |
| dioxygen | multiple interactions | EXP | | 6480464 | Oxygen deficiency inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein]; more ... | CTD | PMID:14652683 |
| dioxygen | decreases expression | EXP | | 6480464 | Oxygen deficiency results in decreased expression of CCL2 mRNA | CTD | PMID:14652683 |
| dioxygen | multiple interactions | ISO | RGD:3645 | 6480464 | Oxygen deficiency results in increased expression of and results in increased secretion of CCL2 protein; more ... | CTD | PMID:18803305 |
| dioxygen | increases expression | ISO | RGD:11275 | 6480464 | Oxygen results in increased expression of CCL2 protein | CTD | PMID:11498801 |
| dioxygen | multiple interactions | ISO | RGD:11275 | 6480464 | valsartan inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 mRNA] | CTD | PMID:18436887 |
| dipyridamole | multiple interactions | ISO | RGD:11275 | 6480464 | Dipyridamole inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | CTD | PMID:16765938 |
| dipyridamole | multiple interactions | ISO | RGD:3645 | 6480464 | Dipyridamole inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; more ... | CTD | PMID:20940016 |
| dobutamine | multiple interactions | EXP | | 6480464 | Dobutamine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:12818967 |
| doxorubicin | multiple interactions | EXP | | 6480464 | Doxorubicin results in increased expression of and results in increased secretion of CCL2 protein | CTD | PMID:12908082 |
| doxorubicin | increases expression | ISO | RGD:3645 | 6480464 | Doxorubicin results in increased expression of CCL2 mRNA | CTD | PMID:11124598 PMID:19915844 |
| doxorubicin | multiple interactions | ISO | RGD:3645 | 6480464 | Razoxane inhibits the reaction [Doxorubicin results in increased expression of CCL2 mRNA] | CTD | PMID:19915844 |
| doxorubicin | increases expression | ISO | RGD:3645 | 6480464 | Doxorubicin results in increased expression of CCL2 mRNA | CTD | PMID:19915844 PMID:11124598 |
| doxorubicin | multiple interactions | ISO | RGD:3645 | 6480464 | Acetylcysteine affects the reaction [Doxorubicin results in increased expression of CCL2 mRNA] | CTD | PMID:11124598 |
| doxorubicin | increases expression | ISO | RGD:3645 | 6480464 | Doxorubicin results in increased expression of CCL2 protein | CTD | PMID:18806609 |
| doxorubicin | increases expression | ISO | RGD:11275 | 6480464 | Doxorubicin results in increased expression of CCL2 mRNA | CTD | PMID:15033991 |
| edaravone | multiple interactions | ISO | RGD:3645 | 6480464 | phenylmethylpyrazolone inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of CCL2 mRNA] | CTD | PMID:12954792 |
| edaravone | decreases expression | ISO | RGD:3645 | 6480464 | phenylmethylpyrazolone results in decreased expression of CCL2 protein | CTD | PMID:19381132 |
| edaravone | decreases expression | ISO | RGD:3645 | 6480464 | phenylmethylpyrazolone results in decreased expression of CCL2 mRNA | CTD | PMID:15948865 |
| edaravone | multiple interactions | ISO | RGD:3645 | 6480464 | phenylmethylpyrazolone inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased secretion of CCL2 protein]; more ... | CTD | PMID:18803305 |
| elemental selenium | multiple interactions | EXP | | 6480464 | Selenium inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:16143069 |
| elemental selenium | multiple interactions | EXP | | 6480464 | [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of CCL2 mRNA | CTD | PMID:21481475 |
| ellagic acid | decreases secretion | EXP | | 6480464 | Ellagic Acid results in decreased secretion of CCL2 protein | CTD | PMID:20816778 |
| emetine | decreases expression | EXP | | 6480464 | Emetine results in decreased expression of CCL2 protein | CTD | PMID:20116850 |
| enalapril | decreases expression | ISO | RGD:3645 | 6480464 | Enalapril results in decreased expression of CCL2 mRNA | CTD | PMID:10925121 |
| enalapril | multiple interactions | ISO | RGD:11275 | 6480464 | [paricalcitol co-treated with Enalapril] results in decreased expression of CCL2 protein | CTD | PMID:20720404 |
| enalapril | decreases expression | ISO | RGD:11275 | 6480464 | Enalapril results in decreased expression of CCL2 protein | CTD | PMID:20720404 |
| enalapril | multiple interactions | ISO | RGD:3645 | 6480464 | [paricalcitol co-treated with Enalapril] results in decreased expression of CCL2 protein | CTD | PMID:17513326 |
| enalapril | decreases expression | ISO | RGD:3645 | 6480464 | Enalapril results in decreased expression of CCL2 mRNA | CTD | PMID:19627010 PMID:10925121 |
| enalapril | decreases expression | ISO | RGD:3645 | 6480464 | Enalapril results in decreased expression of CCL2 mRNA | CTD | PMID:10925121 PMID:19627010 |
| ethanol | multiple interactions | ISO | RGD:11275 | 6480464 | rosiglitazone inhibits the reaction [Ethanol results in increased expression of CCL2 mRNA] | CTD | PMID:22173916 |
| ethanol | increases expression | ISO | RGD:11275 | 6480464 | Ethanol results in increased expression of CCL2 mRNA | CTD | PMID:22173916 |
| ethylene glycol | increases expression | EXP | | 6480464 | Ethylene Glycol results in increased expression of CCL2 mRNA | CTD | PMID:21907259 |
| ethylene glycol | increases expression | ISO | RGD:3645 | 6480464 | Ethylene Glycol results in increased expression of CCL2 protein | CTD | PMID:16284884 |
| ethylene glycol | multiple interactions | ISO | RGD:3645 | 6480464 | Losartan inhibits the reaction [Ethylene Glycol results in increased expression of CCL2 protein]; more ... | CTD | PMID:16284884 |
| eugenol | decreases expression | EXP | | 6480464 | Eugenol results in decreased expression of CCL2 mRNA | CTD | PMID:17936526 PMID:17374397 |
| eugenol | increases secretion | ISO | RGD:11275 | 6480464 | Eugenol results in increased secretion of CCL2 protein | CTD | PMID:22245253 |
| eugenol | increases expression | EXP | | 6480464 | Eugenol results in increased expression of CCL2 mRNA | CTD | PMID:15585374 |
| eugenol | decreases expression | EXP | | 6480464 | Eugenol results in decreased expression of CCL2 mRNA | CTD | PMID:17374397 PMID:17936526 |
| eupatilin | multiple interactions | ISO | RGD:11275 | 6480464 | eupatilin inhibits the reaction [lipopolysaccharide, E. coli 026-B6 results in increased expression of CCL2 mRNA] | CTD | PMID:21565208 |
| felodipine | multiple interactions | ISO | RGD:11275 | 6480464 | Felodipine inhibits the reaction [[APOE gene mutant form affects the susceptibility to Cholesterol, Dietary] which results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:18287887 |
| fenofibrate | multiple interactions | EXP | | 6480464 | Fenofibrate inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:16600694 |
| fenofibrate | multiple interactions | EXP | | 6480464 | Fenofibrate inhibits the reaction [Glucose results in increased expression of CCL2 protein]; more ... | CTD | PMID:19132243 PMID:16600694 |
| fenofibrate | multiple interactions | EXP | | 6480464 | Fenofibrate inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:16600694 PMID:19132243 |
| fenofibrate | multiple interactions | ISO | RGD:11275 | 6480464 | Fenofibrate inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | CTD | PMID:15968640 |
| fenofibrate | decreases expression | ISO | RGD:11275 | 6480464 | Fenofibrate results in decreased expression of CCL2 mRNA; more ... | CTD | PMID:18356826 |
| fenofibrate | multiple interactions | ISO | RGD:11275 | 6480464 | Fenofibrate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | CTD | PMID:16306350 |
| ferroheme b | increases expression | ISO | RGD:11275 | 6480464 | Heme metabolite results in increased expression of CCL2 mRNA | CTD | PMID:19191707 |
| fludrocortisone | decreases expression | EXP | | 6480464 | Fludrocortisone results in decreased expression of CCL2 protein | CTD | PMID:20116850 |
| fluoxetine | decreases secretion | ISO | RGD:11275 | 6480464 | Fluoxetine results in decreased secretion of CCL2 protein | CTD | PMID:21083617 |
| folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of CCL2 protein | CTD | PMID:16491109 |
| folic acid | multiple interactions | ISO | RGD:11275 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CCL2 mRNA | CTD | PMID:20938992 |
| folic acid | multiple interactions | EXP | | 6480464 | Folic Acid inhibits the reaction [Homocysteine results in increased expression of CCL2 mRNA] | CTD | PMID:16845898 |
| formaldehyde | increases expression | ISO | RGD:11275 | 6480464 | Formaldehyde results in increased expression of CCL2 protein | CTD | PMID:15003329 |
| formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of CCL2 mRNA | CTD | PMID:21907259 |
| fructose | increases expression | ISO | RGD:3645 | 6480464 | Fructose results in increased expression of CCL2 protein | CTD | PMID:17133782 PMID:15752949 |
| fructose | multiple interactions | ISO | RGD:3645 | 6480464 | [Copper deficiency co-treated with Fructose] results in increased expression of CCL2 protein | CTD | PMID:21781943 |
| fructose | increases expression | ISO | RGD:3645 | 6480464 | Fructose results in increased expression of CCL2 protein | CTD | PMID:15752949 PMID:17133782 |
| fructose | multiple interactions | ISO | RGD:3645 | 6480464 | Fish Oils inhibits the reaction [Fructose results in increased expression of CCL2 protein] | CTD | PMID:15752949 |
| fructose | increases expression | ISO | RGD:3645 | 6480464 | Fructose results in increased expression of CCL2 mRNA | CTD | PMID:17133782 |
| fructose | multiple interactions | ISO | RGD:3645 | 6480464 | Acarbose inhibits the reaction [Fructose results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:17133782 |
| fructose | increases secretion | EXP | | 6480464 | Fructose results in increased secretion of CCL2 protein | CTD | PMID:19158351 |
| fructose | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Fructose results in increased secretion of CCL2 protein]; more ... | CTD | PMID:19158351 |
| fulvestrant | multiple interactions | EXP | | 6480464 | fulvestrant inhibits the reaction [Estradiol results in decreased activity of CCL2 protein]; more ... | CTD | PMID:17006379 |
| fulvestrant | multiple interactions | EXP | | 6480464 | fulvestrant inhibits the reaction [bisphenol A inhibits the reaction [IL1A protein results in increased secretion of CCL2 protein]]; more ... | CTD | PMID:10614622 |
| gadodiamide hydrate | increases expression | EXP | | 6480464 | gadodiamide results in increased expression of CCL2 mRNA | CTD | PMID:20959327 |
| gadodiamide hydrate | increases expression | ISO | RGD:3645 | 6480464 | gadodiamide results in increased expression of CCL2 protein; more ... | CTD | PMID:20938346 |
| gadodiamide hydrate | increases secretion | EXP | | 6480464 | gadodiamide results in increased secretion of CCL2 protein | CTD | PMID:20959327 |
| genistein | decreases expression | ISO | RGD:3645 | 6480464 | Genistein results in decreased expression of CCL2 mRNA | CTD | PMID:12846738 |
| genistein | decreases expression | ISO | RGD:11275 | 6480464 | Genistein results in decreased expression of CCL2 mRNA | CTD | PMID:21048042 |
| genistein | multiple interactions | EXP | | 6480464 | Genistein inhibits the reaction [LEP protein results in increased expression of CCL2] | CTD | PMID:11342529 |
| genistein | decreases secretion | EXP | | 6480464 | Genistein results in decreased secretion of CCL2 protein | CTD | PMID:20816778 |
| glucose | multiple interactions | EXP | | 6480464 | Aspirin inhibits the reaction [Glucose results in increased expression of CCL2 protein]; more ... | CTD | PMID:16600694 |
| glucose | multiple interactions | EXP | | 6480464 | CCL2 mRNA affects the reaction [Glucose results in increased expression of CTGF protein]; more ... | CTD | PMID:21367880 |
| glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL2 mRNA | CTD | PMID:16143069 more ... |
| glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL2 protein | CTD | PMID:16600694 more ... |
| glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL2 mRNA | CTD | PMID:16143069 more ... |
| glucose | multiple interactions | EXP | | 6480464 | SB 203580 inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | CTD | PMID:16143069 more ... |
| glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL2 mRNA | CTD | PMID:17655880 more ... |
| glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL2 protein | CTD | PMID:16600694 more ... |
| glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL2 mRNA | CTD | PMID:19225232 more ... |
| glucose | multiple interactions | EXP | | 6480464 | SB 203580 inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | CTD | PMID:16143069 more ... |
| glucose | multiple interactions | EXP | | 6480464 | PD 98059 inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:19132243 |
| glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL2 protein | CTD | PMID:19132243 more ... |
| glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL2 mRNA | CTD | PMID:19132243 more ... |
| glucose | multiple interactions | EXP | | 6480464 | Clofibrate inhibits the reaction [Glucose results in increased expression of CCL2 protein]; more ... | CTD | PMID:19132243 PMID:16600694 |
| glucose | multiple interactions | EXP | | 6480464 | Clofibrate inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:16600694 PMID:19132243 |
| glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL2 protein | CTD | PMID:16600694 PMID:17655880 |
| glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL2 mRNA | CTD | PMID:16143069 more ... |
| glucose | multiple interactions | EXP | | 6480464 | SB 203580 inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | CTD | PMID:17655880 PMID:16143069 |
| glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL2 mRNA | CTD | PMID:16600694 more ... |
| glucose | increases expression | ISO | RGD:11275 | 6480464 | Glucose results in increased expression of CCL2 mRNA | CTD | PMID:17178593 |
| glucose | increases expression | ISO | RGD:11275 | 6480464 | Glucose results in increased expression of CCL2 protein | CTD | PMID:17607302 |
| glucose | multiple interactions | EXP | | 6480464 | Selenium inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | CTD | PMID:16143069 |
| glucose | multiple interactions | EXP | | 6480464 | SB 203580 inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | CTD | PMID:16143069 PMID:17655880 |
| glucose | multiple interactions | EXP | | 6480464 | psicose inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:17655880 |
| glucose | increases secretion | EXP | | 6480464 | Glucose results in increased secretion of CCL2 protein | CTD | PMID:16600694 |
| glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL2 protein | CTD | PMID:17655880 PMID:16600694 |
| glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL2 mRNA | CTD | PMID:17655880 more ... |
| glucose | multiple interactions | EXP | | 6480464 | Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:19225232 |
| glucose | multiple interactions | EXP | | 6480464 | Glucose inhibits the reaction [Fructose results in increased secretion of CCL2 protein] | CTD | PMID:19158351 |
| gold atom | multiple interactions | ISO | RGD:11275 | 6480464 | [Gold co-treated with Silicon Dioxide] results in increased secretion of CCL2 protein | CTD | PMID:22155353 |
| gold atom | increases secretion | ISO | RGD:11275 | 6480464 | Gold results in increased secretion of CCL2 protein | CTD | PMID:22155353 |
| gold(0) | multiple interactions | ISO | RGD:11275 | 6480464 | [Gold co-treated with Silicon Dioxide] results in increased secretion of CCL2 protein | CTD | PMID:22155353 |
| gold(0) | increases secretion | ISO | RGD:11275 | 6480464 | Gold results in increased secretion of CCL2 protein | CTD | PMID:22155353 |
| halothane | decreases expression | ISO | RGD:3645 | 6480464 | Halothane results in decreased expression of CCL2 mRNA | CTD | PMID:15564938 |
| harmaline | multiple interactions | EXP | | 6480464 | Harmaline inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein] | CTD | PMID:12107048 |
| heparin | decreases expression | ISO | RGD:3645 | 6480464 | Heparin results in decreased expression of CCL2 protein | CTD | PMID:11053056 |
| histamine | multiple interactions | EXP | | 6480464 | TNF protein promotes the reaction [Histamine results in increased expression of CCL2 protein]; more ... | CTD | PMID:11336536 |
| hyaluronic acid | increases secretion | ISO | RGD:11275 | 6480464 | Hyaluronic Acid results in increased secretion of CCL2 protein | CTD | PMID:23010656 |
| hyaluronic acid | multiple interactions | ISO | RGD:11275 | 6480464 | CASP1 gene mutant form inhibits the reaction [Hyaluronic Acid results in increased secretion of CCL2 protein]; more ... | CTD | PMID:23010656 |
| hydrogen chloride | increases expression | ISO | RGD:3645 | 6480464 | Hydrochloric Acid results in increased expression of CCL2 protein; more ... | CTD | PMID:16129981 |
| hydrogen chloride | multiple interactions | ISO | RGD:3645 | 6480464 | pyrrolidine dithiocarbamic acid inhibits the reaction [Hydrochloric Acid results in increased expression of CCL2 protein]; more ... | CTD | PMID:16129981 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of CCL2 mRNA | CTD | PMID:16143069 PMID:12419474 |
| hydrogen peroxide | increases secretion | ISO | RGD:11275 | 6480464 | Hydrogen Peroxide results in increased secretion of CCL2 protein | CTD | PMID:18303122 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of CCL2 protein | CTD | PMID:18951874 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of CCL2 mRNA | CTD | PMID:12419474 PMID:16143069 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:16143069 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of CCL2 protein | CTD | PMID:17529908 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | Hydrogen Peroxide promotes the reaction [ALB protein results in increased expression of CCL2 mRNA] | CTD | PMID:11961005 |
| hydroquinone | increases expression | EXP | | 6480464 | hydroquinone results in increased expression of CCL2 protein | CTD | PMID:17572062 |
| hydroquinone | decreases secretion | ISO | RGD:11275 | 6480464 | hydroquinone results in decreased secretion of CCL2 protein | CTD | PMID:22465845 |
| hydroquinone | multiple interactions | ISO | RGD:11275 | 6480464 | hydroquinone inhibits the reaction [lipopolysaccharide, E. coli 026-B6 results in increased secretion of CCL2 protein]; more ... | CTD | PMID:22465845 |
| hydroquinone | decreases expression | ISO | RGD:11275 | 6480464 | hydroquinone results in decreased expression of CCL2 mRNA | CTD | PMID:22465845 |
| hydroquinone | increases secretion | EXP | | 6480464 | hydroquinone results in increased secretion of CCL2 protein | CTD | PMID:20946948 |
| ibuprofen | multiple interactions | EXP | | 6480464 | Ibuprofen inhibits the reaction [IL1A protein results in increased secretion of CCL2 protein] | CTD | PMID:11230753 |
| ibuprofen | multiple interactions | ISO | RGD:11275 | 6480464 | Ibuprofen inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:18799549 |
| ibuprofen | increases expression | EXP | | 6480464 | Ibuprofen results in increased expression of CCL2 mRNA | CTD | PMID:17070997 |
| imatinib | multiple interactions | EXP | | 6480464 | imatinib inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased secretion of CCL2 protein] | CTD | PMID:21935477 |
| indinavir | increases expression | EXP | | 6480464 | Indinavir results in increased expression of CCL2 protein | CTD | PMID:17668557 |
| indinavir | multiple interactions | EXP | | 6480464 | diphenyleneiodonium inhibits the reaction [Indinavir results in increased expression of CCL2 protein] | CTD | PMID:17668557 |
| indomethacin | multiple interactions | EXP | | 6480464 | Indomethacin inhibits the reaction [IL1A protein results in increased secretion of CCL2 protein] | CTD | PMID:11230753 |
| indomethacin | multiple interactions | ISO | RGD:11275 | 6480464 | Indomethacin inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:18799549 |
| indomethacin | multiple interactions | EXP | | 6480464 | Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]]; more ... | CTD | PMID:21913898 |
| indoxyl sulfate | increases expression | EXP | | 6480464 | Indican results in increased expression of CCL2 mRNA; more ... | CTD | PMID:22056374 |
| ionomycin | multiple interactions | EXP | | 6480464 | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCL2 protein | CTD | PMID:17572062 |
| irbesartan | multiple interactions | ISO | RGD:11275 | 6480464 | Cholesterol inhibits the reaction [irbesartan results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:19028402 |
| iron atom | multiple interactions | ISO | RGD:3645 | 6480464 | Iron promotes the reaction [[Copper co-treated with Diethylnitrosamine] results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:20302851 |
| iron atom | increases expression | EXP | | 6480464 | Iron deficiency results in increased expression of CCL2 mRNA | CTD | PMID:20368581 |
| isoeugenol | decreases secretion | EXP | | 6480464 | isoeugenol results in decreased secretion of CCL2 protein | CTD | PMID:20488241 |
| isoflurane | decreases expression | ISO | RGD:3645 | 6480464 | Isoflurane results in decreased expression of CCL2 mRNA | CTD | PMID:15564938 |
| isoprenaline | increases expression | ISO | RGD:11275 | 6480464 | Isoproterenol results in increased expression of CCL2 mRNA | CTD | PMID:21823215 |
| isotretinoin | decreases expression | ISO | RGD:3645 | 6480464 | Isotretinoin results in decreased expression of CCL2 mRNA | CTD | PMID:15972972 |
| kaempferol | multiple interactions | ISO | RGD:11275 | 6480464 | kaempferol inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:16434028 |
| kaempferol 3-O-glucoside | multiple interactions | ISO | RGD:11275 | 6480464 | astragalin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | CTD | PMID:22210036 |
| kainic acid | increases expression | ISO | RGD:3645 | 6480464 | Kainic Acid results in increased expression of CCL2 mRNA | CTD | PMID:19700661 |
| L-ascorbic acid | affects expression | EXP | | 6480464 | Ascorbic Acid deficiency affects the expression of CCL2 mRNA; more ... | CTD | PMID:19932582 |
| L-ascorbic acid | decreases expression | ISO | RGD:11275 | 6480464 | Ascorbic Acid results in decreased expression of CCL2 mRNA | CTD | PMID:21796779 |
| L-methionine | multiple interactions | ISO | RGD:11275 | 6480464 | Bezafibrate inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of CCL2 mRNA] | CTD | PMID:18513333 |
| L-methionine | multiple interactions | ISO | RGD:11275 | 6480464 | [Methionine deficiency co-treated with Choline deficiency] results in increased expression of CCL2 mRNA; more ... | CTD | PMID:23038002 |
| L-methionine | multiple interactions | ISO | RGD:11275 | 6480464 | CCL2 protein inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of ACTA2 protein]; more ... | CTD | PMID:20697377 |
| L-methionine | multiple interactions | ISO | RGD:11275 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CCL2 mRNA | CTD | PMID:20938992 |
| lead diacetate | decreases expression | ISO | RGD:11275 | 6480464 | lead acetate results in decreased expression of CCL2 mRNA | CTD | PMID:21829687 |
| lead(0) | increases expression | ISO | RGD:3645 | 6480464 | Lead results in increased expression of CCL2 mRNA | CTD | PMID:17715263 |
| leptomycin B | increases secretion | EXP | | 6480464 | leptomycin B results in increased secretion of CCL2 protein | CTD | PMID:21967610 |
| leptomycin B | multiple interactions | EXP | | 6480464 | polydatin inhibits the reaction [leptomycin B results in increased secretion of CCL2 protein] | CTD | PMID:21967610 |
| leukotriene B4 | increases expression | ISO | RGD:11275 | 6480464 | Leukotriene B4 results in increased expression of CCL2 protein | CTD | PMID:19880577 |
| leukotriene B4 | increases abundance | ISO | RGD:11275 | 6480464 | CCL2 protein results in increased abundance of Leukotriene B4 | CTD | PMID:12388339 |
| leukotriene B4 | multiple interactions | ISO | RGD:11275 | 6480464 | zileuton inhibits the reaction [CCL2 protein results in increased abundance of Leukotriene B4] | CTD | PMID:12388339 |
| leukotriene C4 | increases expression | ISO | RGD:11275 | 6480464 | Leukotriene C4 results in increased expression of CCL2 mRNA | CTD | PMID:12388339 |
| lidocaine | multiple interactions | EXP | | 6480464 | Lidocaine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:14570645 |
| lipoic acid | multiple interactions | ISO | RGD:11275 | 6480464 | Thioctic Acid inhibits the reaction [arsenic trioxide results in increased expression of CCL2 mRNA] | CTD | PMID:22488045 |
| loganin | affects expression | ISO | RGD:11275 | 6480464 | loganin affects the expression of CCL2 protein | CTD | PMID:21864639 |
| losartan | decreases expression | ISO | RGD:3645 | 6480464 | Losartan results in decreased expression of CCL2 protein | CTD | PMID:17922026 |
| losartan | multiple interactions | ISO | RGD:3645 | 6480464 | Losartan inhibits the reaction [Ethylene Glycol results in increased expression of CCL2 protein] | CTD | PMID:16284884 |
| losartan | multiple interactions | ISO | RGD:3645 | 6480464 | Losartan inhibits the reaction [Estrogens deficiency results in increased expression of CCL2 protein] | CTD | PMID:19553526 |
| losartan | decreases expression | ISO | RGD:3645 | 6480464 | Losartan results in decreased expression of CCL2 mRNA | CTD | PMID:10925121 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Digitoxin inhibits the reaction [IL1B protein results in increased expression of CCL2 protein]] | CTD | PMID:19446813 |
| LY294002 | multiple interactions | ISO | RGD:11275 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | CTD | PMID:19293636 PMID:22225513 |
| LY294002 | multiple interactions | ISO | RGD:11275 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | CTD | PMID:22225513 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | CTD | PMID:16794257 |
| LY294002 | multiple interactions | ISO | RGD:11275 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cocaine results in increased expression of CCL2 protein] | CTD | PMID:20354174 |
| m-xylene | increases expression | ISO | RGD:3645 | 6480464 | 3-xylene results in increased expression of CCL2 protein | CTD | PMID:15902427 |
| m-xylene | increases expression | EXP | | 6480464 | 3-xylene results in increased expression of CCL2 protein | CTD | PMID:17993253 |
| manganese atom | increases expression | ISO | RGD:3645 | 6480464 | Manganese results in increased expression of CCL2 mRNA | CTD | PMID:19782702 |
| manganese(0) | increases expression | ISO | RGD:3645 | 6480464 | Manganese results in increased expression of CCL2 mRNA | CTD | PMID:19782702 |
| mangiferin | decreases expression | ISO | RGD:11275 | 6480464 | mangiferin results in decreased expression of CCL2 mRNA | CTD | PMID:15135318 |
| mebendazole | increases expression | EXP | | 6480464 | Mebendazole results in increased expression of CCL2 protein | CTD | PMID:20116850 |
| melamine | multiple interactions | EXP | | 6480464 | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [melamine results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:22915474 |
| melamine | increases expression | EXP | | 6480464 | melamine results in increased expression of CCL2 mRNA | CTD | PMID:22915474 |
| melatonin | multiple interactions | ISO | RGD:11275 | 6480464 | Melatonin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:22225513 |
| metformin | decreases expression | EXP | | 6480464 | Metformin results in decreased expression of CCL2 mRNA | CTD | PMID:20956498 |
| methadone | increases secretion | ISO | RGD:3645 | 6480464 | Methadone results in increased secretion of CCL2 protein | CTD | PMID:20178837 |
| methionine sulfoximine | decreases expression | EXP | | 6480464 | Methionine Sulfoximine results in decreased expression of CCL2 protein | CTD | PMID:20116850 |
| methotrexate | decreases expression | EXP | | 6480464 | Methotrexate results in decreased expression of CCL2 mRNA | CTD | PMID:17400583 |
| methyl methacrylate | increases expression | EXP | | 6480464 | Methylmethacrylate results in increased expression of CCL2 mRNA | CTD | PMID:17498896 |
| methylglyoxal | increases expression | ISO | RGD:11275 | 6480464 | Pyruvaldehyde results in increased expression of CCL2 protein | CTD | PMID:22101032 |
| methylglyoxal | multiple interactions | ISO | RGD:11275 | 6480464 | epigallocatechin gallate inhibits the reaction [Pyruvaldehyde results in increased expression of CCL2 protein] | CTD | PMID:22101032 |
| mevalonic acid | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [atorvastatin inhibits the reaction [TNF results in increased expression of CCL2 mRNA]]; more ... | CTD | PMID:12117737 |
| mevalonic acid | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased expression of CCL2 mRNA]] | CTD | PMID:16321392 PMID:12117737 |
| mevalonic acid | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased expression of CCL2 mRNA]] | CTD | PMID:12117737 PMID:16321392 |
| mevalonic acid | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [IFNG results in increased expression of CCL2 mRNA]] | CTD | PMID:16321392 |
| minocycline | decreases expression | EXP | | 6480464 | Minocycline results in decreased expression of CCL2 protein | CTD | PMID:20116850 |
| mitomycin C | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [Mitomycin results in increased secretion of CCL2 protein]; more ... | CTD | PMID:20002897 |
| mitomycin C | increases secretion | EXP | | 6480464 | Mitomycin results in increased secretion of CCL2 protein | CTD | PMID:20002897 |
| mitomycin C | increases expression | EXP | | 6480464 | Mitomycin results in increased expression of CCL2 mRNA | CTD | PMID:20002897 |
| montelukast | multiple interactions | EXP | | 6480464 | montelukast inhibits the reaction [CCL2 protein results in increased abundance of Calcium] | CTD | PMID:16771778 |
| morphine | increases secretion | ISO | RGD:3645 | 6480464 | Morphine results in increased secretion of CCL2 protein | CTD | PMID:20178837 |
| mycophenolate mofetil | multiple interactions | ISO | RGD:3645 | 6480464 | mycophenolate mofetil inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:17624267 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Chloroquine results in increased expression of CCL2 mRNA] | CTD | PMID:15139008 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:11275 | 6480464 | Acetylcysteine inhibits the reaction [Palmitates results in increased secretion of CCL2 protein] | CTD | PMID:18303122 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:11275 | 6480464 | Acetylcysteine inhibits the reaction [[Silicon Dioxide co-treated with Lipopolysaccharides] results in increased secretion of CCL2 protein] | CTD | PMID:22815821 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:3645 | 6480464 | Acetylcysteine inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] | CTD | PMID:10541287 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:3645 | 6480464 | Acetylcysteine affects the reaction [Doxorubicin results in increased expression of CCL2 mRNA] | CTD | PMID:11124598 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Fructose results in increased secretion of CCL2 protein] | CTD | PMID:19158351 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | CTD | PMID:17529908 |
| N-ethyl-5'-carboxamidoadenosine | increases secretion | EXP | | 6480464 | Adenosine-5'-(N-ethylcarboxamide) results in increased secretion of CCL2 protein | CTD | PMID:17696452 |
| N-methyl-N-nitrosurea | multiple interactions | ISO | RGD:11275 | 6480464 | Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of CCL2 protein]; more ... | CTD | PMID:16822543 |
| N-methyl-N-nitrosurea | increases expression | ISO | RGD:3645 | 6480464 | Methylnitrosourea results in increased expression of CCL2 mRNA | CTD | PMID:17412507 |
| N-methyl-N-nitrosurea | increases expression | ISO | RGD:11275 | 6480464 | Methylnitrosourea results in increased expression of CCL2 protein | CTD | PMID:16822543 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:3645 | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCL2 mRNA; more ... | CTD | PMID:21295105 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:3645 | 6480464 | [Copper co-treated with Diethylnitrosamine] results in increased expression of CCL2 mRNA; more ... | CTD | PMID:20302851 |
| N-nitrosodimethylamine | increases expression | ISO | RGD:3645 | 6480464 | Dimethylnitrosamine results in increased expression of CCL2 protein | CTD | PMID:17719030 |
| N-tosyl-L-phenylalanyl chloromethyl ketone | multiple interactions | EXP | | 6480464 | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Chloroquine results in increased expression of CCL2 mRNA] | CTD | PMID:15139008 |
| N-tosyl-L-phenylalanyl chloromethyl ketone | decreases expression | ISO | RGD:3645 | 6480464 | Tosylphenylalanyl Chloromethyl Ketone results in decreased expression of CCL2 mRNA | CTD | PMID:12846738 |
| N-tosyl-L-phenylalanyl chloromethyl ketone | multiple interactions | EXP | | 6480464 | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [IL17A protein results in increased expression of CCL2 mRNA] | CTD | PMID:12016129 |
| N-tosyl-L-phenylalanyl chloromethyl ketone | multiple interactions | ISO | RGD:11275 | 6480464 | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | CTD | PMID:18706406 |
| N-tosyl-L-phenylalanyl chloromethyl ketone | multiple interactions | EXP | | 6480464 | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:16600694 |
| naloxone | multiple interactions | EXP | | 6480464 | Naloxone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | CTD | PMID:17084265 |
| naphthalene | increases expression | ISO | RGD:11275 | 6480464 | naphthalene results in increased expression of CCL2 mRNA | CTD | PMID:18978301 |
| naproxen | multiple interactions | ISO | RGD:3645 | 6480464 | [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CCL2 protein]; more ... | CTD | PMID:22150557 |
| nickel dichloride | decreases expression | ISO | RGD:11275 | 6480464 | nickel chloride results in decreased expression of CCL2 mRNA | CTD | PMID:12839937 |
| nickel dichloride | increases expression | EXP | | 6480464 | nickel chloride results in increased expression of CCL2 mRNA | CTD | PMID:17312168 |
| nickel dichloride | decreases secretion | EXP | | 6480464 | nickel chloride results in decreased secretion of CCL2 protein | CTD | PMID:18437699 |
| nickel sulfate | increases expression | ISO | RGD:11275 | 6480464 | nickel sulfate results in increased expression of CCL2 mRNA | CTD | PMID:16100012 |
| nickel sulfate | increases expression | ISO | RGD:11275 | 6480464 | nickel sulfate results in increased expression of CCL2 mRNA | CTD | PMID:16100012 PMID:16166746 |
| nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of CCL2 mRNA | CTD | PMID:12060402 more ... |
| nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of CCL2 mRNA | CTD | PMID:15585374 more ... |
| nickel sulfate | increases expression | ISO | RGD:11275 | 6480464 | nickel sulfate results in increased expression of CCL2 mRNA | CTD | PMID:16166746 PMID:16100012 |
| nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of CCL2 mRNA | CTD | PMID:12060402 more ... |
| nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of CCL2 mRNA | CTD | PMID:15585374 PMID:16780908 |
| nickel sulfate | decreases expression | EXP | | 6480464 | nickel sulfate results in decreased expression of CCL2 mRNA | CTD | PMID:17374397 |
| nickel sulfate | multiple interactions | EXP | | 6480464 | [macrophage stimulatory lipopeptide 2 co-treated with nickel sulfate] results in increased expression of CCL2 mRNA | CTD | PMID:18832182 |
| nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of CCL2 mRNA | CTD | PMID:16780908 |
| nicotinamide | decreases expression | EXP | | 6480464 | Niacinamide results in decreased expression of CCL2 protein | CTD | PMID:14627904 |
| nicotinic acid | decreases expression | EXP | | 6480464 | Niacin results in decreased expression of CCL2 protein | CTD | PMID:18550065 |
| nicotinic acid | decreases expression | ISO | RGD:3645 | 6480464 | Niacin results in decreased expression of CCL2 protein | CTD | PMID:19420110 |
| nicotinic acid | multiple interactions | EXP | | 6480464 | Niacin inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | CTD | PMID:18550065 |
| nimesulide | decreases expression | EXP | | 6480464 | nimesulide results in decreased expression of CCL2 protein | CTD | PMID:17380299 |
| nimesulide | multiple interactions | ISO | RGD:11275 | 6480464 | [nimesulide results in decreased activity of PTGS2 protein] which results in increased expression of CCL2 mRNA | CTD | PMID:22561872 |
| nimesulide | multiple interactions | ISO | RGD:3645 | 6480464 | nimesulide inhibits the reaction [Dietary Fats results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:20039930 |
| nitrogen dioxide | increases expression | ISO | RGD:11275 | 6480464 | Nitrogen Dioxide results in increased expression of CCL2 mRNA | CTD | PMID:10715624 |
| nitrogen dioxide | increases expression | ISO | RGD:11275 | 6480464 | Nitrogen Dioxide results in increased expression of CCL2 protein | CTD | PMID:11498801 |
| nitroprusside | multiple interactions | ISO | RGD:11275 | 6480464 | [Nitroprusside co-treated with TNFA co-treated with IFNG] results in increased expression of CCL2 mRNA | CTD | PMID:15153526 |
| nocodazole | increases expression | EXP | | 6480464 | Nocodazole results in increased expression of CCL2 protein | CTD | PMID:20116850 |
| ouabain | multiple interactions | ISO | RGD:3645 | 6480464 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Ouabain results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:11340305 |
| ouabain | increases expression | ISO | RGD:3645 | 6480464 | Ouabain results in increased expression of CCL2 mRNA; more ... | CTD | PMID:11340305 |
| oxytetracycline | decreases expression | EXP | | 6480464 | Oxytetracycline results in decreased expression of CCL2 protein | CTD | PMID:20116850 |
| ozone | multiple interactions | ISO | RGD:11275 | 6480464 | [Acetaminophen co-treated with Ozone] results in increased expression of CCL2 mRNA; more ... | CTD | PMID:20123758 |
| ozone | increases secretion | ISO | RGD:11275 | 6480464 | Ozone results in increased secretion of CCL2 protein | CTD | PMID:23010656 |
| ozone | multiple interactions | ISO | RGD:11275 | 6480464 | CASP1 gene mutant form inhibits the reaction [Ozone results in increased secretion of CCL2 protein]; more ... | CTD | PMID:23010656 |
| ozone | increases expression | ISO | RGD:3645 | 6480464 | Ozone results in increased expression of CCL2 mRNA | CTD | PMID:16716893 more ... |
| ozone | increases expression | ISO | RGD:11275 | 6480464 | Ozone results in increased expression of CCL2 protein | CTD | PMID:11498801 more ... |
| ozone | increases expression | ISO | RGD:11275 | 6480464 | Ozone results in increased expression of CCL2 mRNA | CTD | PMID:12217210 more ... |
| ozone | increases expression | ISO | RGD:11275 | 6480464 | Ozone results in increased expression of CCL2 mRNA | CTD | PMID:15371095 more ... |
| ozone | increases expression | ISO | RGD:11275 | 6480464 | Ozone results in increased expression of CCL2 protein | CTD | PMID:11498801 more ... |
| ozone | increases expression | ISO | RGD:11275 | 6480464 | Ozone results in increased expression of CCL2 mRNA | CTD | PMID:12217210 more ... |
| ozone | increases expression | ISO | RGD:11275 | 6480464 | Ozone results in increased expression of CCL2 protein | CTD | PMID:18929643 more ... |
| ozone | increases expression | ISO | RGD:3645 | 6480464 | Ozone results in increased expression of CCL2 mRNA | CTD | PMID:16716893 PMID:9458799 |
| ozone | increases expression | ISO | RGD:11275 | 6480464 | Ozone results in increased expression of CCL2 protein | CTD | PMID:11498801 more ... |
| ozone | increases expression | ISO | RGD:11275 | 6480464 | Ozone results in increased expression of CCL2 mRNA | CTD | PMID:15371095 more ... |
| ozone | increases expression | ISO | RGD:11275 | 6480464 | Ozone results in increased expression of CCL2 protein | CTD | PMID:11498801 more ... |
| ozone | increases expression | ISO | RGD:11275 | 6480464 | Ozone results in increased expression of CCL2 mRNA | CTD | PMID:12763052 more ... |
| ozone | increases expression | ISO | RGD:11275 | 6480464 | Ozone results in increased expression of CCL2 mRNA | CTD | PMID:14754758 more ... |
| ozone | increases expression | ISO | RGD:11275 | 6480464 | Ozone results in increased expression of CCL2 protein | CTD | PMID:11498801 more ... |
| ozone | increases expression | ISO | RGD:3645 | 6480464 | Ozone results in increased expression of CCL2 mRNA | CTD | PMID:9458799 PMID:16716893 |
| ozone | increases expression | ISO | RGD:11275 | 6480464 | Ozone results in increased expression of CCL2 protein | CTD | PMID:18929643 more ... |
| ozone | increases expression | ISO | RGD:11275 | 6480464 | Ozone results in increased expression of CCL2 mRNA | CTD | PMID:12217210 more ... |
| ozone | multiple interactions | ISO | RGD:11275 | 6480464 | Endotoxins promotes the reaction [Ozone results in increased expression of CCL2 mRNA] | CTD | PMID:12217210 |
| ozone | multiple interactions | ISO | RGD:11275 | 6480464 | CPE gene mutant form promotes the reaction [Ozone results in increased expression of CCL2 protein] | CTD | PMID:16002559 |
| ozone | multiple interactions | ISO | RGD:11275 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one promotes the reaction [Ozone results in increased expression of CCL2 mRNA] | CTD | PMID:17460151 |
| paclitaxel | increases response to substance | EXP | | 6480464 | CCL2 results in increased susceptibility to Paclitaxel | CTD | PMID:21187454 |
| palmatine | decreases expression | EXP | | 6480464 | palmatine results in decreased expression of CCL2 protein | CTD | PMID:20116850 |
| paracetamol | increases expression | ISO | RGD:11275 | 6480464 | Acetaminophen results in increased expression of CCL2 protein | CTD | PMID:11981759 more ... |
| paracetamol | multiple interactions | ISO | RGD:11275 | 6480464 | MST1R protein affects the reaction [Acetaminophen results in increased expression of CCL2 mRNA] | CTD | PMID:22575169 |
| paracetamol | increases expression | ISO | RGD:11275 | 6480464 | Acetaminophen results in increased expression of CCL2 mRNA | CTD | PMID:12153990 more ... |
| paracetamol | multiple interactions | ISO | RGD:11275 | 6480464 | CAV1 affects the reaction [Acetaminophen results in increased expression of CCL2 mRNA] | CTD | PMID:20100502 |
| paracetamol | increases expression | ISO | RGD:11275 | 6480464 | Acetaminophen results in increased expression of CCL2 protein | CTD | PMID:11981759 more ... |
| paracetamol | increases expression | ISO | RGD:11275 | 6480464 | Acetaminophen results in increased expression of CCL2 mRNA | CTD | PMID:12153990 more ... |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of CCL2 mRNA | CTD | PMID:21420995 |
| paracetamol | increases expression | ISO | RGD:11275 | 6480464 | Acetaminophen results in increased expression of CCL2 protein | CTD | PMID:16081117 more ... |
| paracetamol | increases expression | ISO | RGD:11275 | 6480464 | Acetaminophen results in increased expression of CCL2 mRNA | CTD | PMID:14557383 more ... |
| paracetamol | multiple interactions | ISO | RGD:11275 | 6480464 | TNFRSF1A protein promotes the reaction [Acetaminophen results in increased expression of CCL2 mRNA] | CTD | PMID:14557383 PMID:14550746 |
| paracetamol | increases expression | ISO | RGD:11275 | 6480464 | Acetaminophen results in increased expression of CCL2 protein | CTD | PMID:19799668 more ... |
| paracetamol | increases expression | ISO | RGD:11275 | 6480464 | Acetaminophen results in increased expression of CCL2 mRNA | CTD | PMID:12153990 more ... |
| paracetamol | increases expression | ISO | RGD:3645 | 6480464 | Acetaminophen results in increased expression of CCL2 protein | CTD | PMID:16687475 |
| paracetamol | multiple interactions | ISO | RGD:11275 | 6480464 | TNFRSF1A protein promotes the reaction [Acetaminophen results in increased expression of CCL2 mRNA] | CTD | PMID:14550746 PMID:14557383 |
| paracetamol | multiple interactions | ISO | RGD:11275 | 6480464 | TNFRSF1A protein promotes the reaction [Acetaminophen results in increased expression of CCL2 protein] | CTD | PMID:14557383 |
| paracetamol | increases expression | ISO | RGD:11275 | 6480464 | Acetaminophen results in increased expression of CCL2 mRNA | CTD | PMID:20123758 more ... |
| paracetamol | multiple interactions | ISO | RGD:11275 | 6480464 | IFNG protein promotes the reaction [Acetaminophen results in increased expression of CCL2 mRNA] | CTD | PMID:12153990 |
| paracetamol | multiple interactions | ISO | RGD:11275 | 6480464 | KLRB1C protein promotes the reaction [Acetaminophen results in increased expression of CCL2 mRNA] | CTD | PMID:15578514 |
| paracetamol | increases expression | ISO | RGD:11275 | 6480464 | Acetaminophen results in increased expression of CCL2 protein | CTD | PMID:14557383 more ... |
| paracetamol | multiple interactions | ISO | RGD:11275 | 6480464 | Carnosine inhibits the reaction [Acetaminophen results in increased expression of CCL2 protein]; more ... | CTD | PMID:19799668 |
| paracetamol | affects expression | ISO | RGD:11275 | 6480464 | Acetaminophen affects the expression of CCL2 mRNA | CTD | PMID:17562736 |
| paracetamol | multiple interactions | ISO | RGD:11275 | 6480464 | [Acetaminophen co-treated with Ozone] results in increased expression of CCL2 mRNA; more ... | CTD | PMID:20123758 |
| paracetamol | increases expression | ISO | RGD:11275 | 6480464 | Acetaminophen results in increased expression of CCL2 protein | CTD | PMID:11981759 more ... |
| paracetamol | increases expression | ISO | RGD:11275 | 6480464 | Acetaminophen results in increased expression of CCL2 mRNA | CTD | PMID:16552707 more ... |
| paracetamol | increases expression | ISO | RGD:11275 | 6480464 | Acetaminophen results in increased expression of CCL2 mRNA | CTD | PMID:16552707 more ... |
| paracetamol | increases expression | ISO | RGD:11275 | 6480464 | Acetaminophen results in increased expression of CCL2 protein | CTD | PMID:19799668 more ... |
| paracetamol | increases expression | ISO | RGD:11275 | 6480464 | Acetaminophen results in increased expression of CCL2 mRNA | CTD | PMID:16552707 more ... |
| paraquat | increases expression | ISO | RGD:11275 | 6480464 | Paraquat results in increased expression of CCL2 mRNA | CTD | PMID:16324872 |
| paraquat | increases expression | ISO | RGD:3645 | 6480464 | Paraquat results in increased expression of CCL2 mRNA | CTD | PMID:21921364 |
| paraquat | multiple interactions | ISO | RGD:3645 | 6480464 | Ambroxol affects the reaction [Paraquat results in increased expression of CCL2 mRNA] | CTD | PMID:21921364 |
| paricalcitol | multiple interactions | ISO | RGD:3645 | 6480464 | [paricalcitol co-treated with Enalapril] results in decreased expression of CCL2 protein | CTD | PMID:17513326 |
| paricalcitol | decreases expression | ISO | RGD:11275 | 6480464 | paricalcitol results in decreased expression of CCL2 protein | CTD | PMID:20720404 |
| paricalcitol | multiple interactions | ISO | RGD:11275 | 6480464 | [paricalcitol co-treated with Enalapril] results in decreased expression of CCL2 protein | CTD | PMID:20720404 |
| PD123319 | multiple interactions | ISO | RGD:3645 | 6480464 | PD 123319 inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | CTD | PMID:15284299 |
| perindopril | decreases expression | EXP | | 6480464 | Perindopril results in decreased expression of CCL2 protein | CTD | PMID:19840533 |
| phenethyl isothiocyanate | multiple interactions | ISO | RGD:11275 | 6480464 | phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | CTD | PMID:20423518 |
| phenol | increases expression | EXP | | 6480464 | Phenol results in increased expression of CCL2 mRNA | CTD | PMID:21907259 |
| phenylephrine | multiple interactions | ISO | RGD:3645 | 6480464 | 4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid inhibits the reaction [Phenylephrine results in increased expression of CCL2 mRNA] | CTD | PMID:15721863 |
| phenylephrine | increases expression | ISO | RGD:3645 | 6480464 | Phenylephrine results in increased expression of CCL2 protein | CTD | PMID:15721863 |
| phenylephrine | increases expression | ISO | RGD:3645 | 6480464 | Phenylephrine results in increased expression of CCL2 mRNA | CTD | PMID:15728586 |
| phenylephrine | multiple interactions | ISO | RGD:3645 | 6480464 | parthenolide inhibits the reaction [Phenylephrine results in increased expression of CCL2 mRNA] | CTD | PMID:15728586 |
| phenytoin | increases expression | ISO | RGD:3645 | 6480464 | Phenytoin results in increased expression of CCL2 protein | CTD | PMID:14578793 |
| phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | scoparone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:16376386 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:11275 | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:19945525 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:11275 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA | CTD | PMID:19063610 PMID:19945525 |
| phorbol 13-acetate 12-myristate | increases secretion | EXP | | 6480464 | Tetradecanoylphorbol Acetate results in increased secretion of CCL2 protein | CTD | PMID:16376386 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:11275 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA | CTD | PMID:19063610 |
| phorbol 13-acetate 12-myristate | increases expression | EXP | | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA | CTD | PMID:16376386 |
| phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCL2 protein | CTD | PMID:17572062 |
| phthalaldehyde | multiple interactions | ISO | RGD:11275 | 6480464 | [o-Phthalaldehyde co-treated with SERPINB14 protein] results in increased expression of CCL2 mRNA | CTD | PMID:19110043 |
| phthalic anhydride | increases expression | ISO | RGD:11275 | 6480464 | phthalic anhydride results in increased expression of CCL2 protein | CTD | PMID:20219652 |
| pioglitazone | multiple interactions | EXP | | 6480464 | [pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCL2 mRNA | CTD | PMID:20847119 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | pirinixic acid inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | CTD | PMID:19693652 |
| pirinixic acid | increases expression | ISO | RGD:11275 | 6480464 | pirinixic acid results in increased expression of CCL2 mRNA | CTD | PMID:8764118 |
| pirinixic acid | decreases expression | ISO | RGD:11275 | 6480464 | pirinixic acid results in decreased expression of CCL2 protein; more ... | CTD | PMID:17888025 PMID:18356826 |
| pirinixic acid | decreases expression | ISO | RGD:11275 | 6480464 | pirinixic acid results in decreased expression of CCL2 mRNA; more ... | CTD | PMID:18356826 PMID:17888025 |
| pirinixic acid | multiple interactions | ISO | RGD:11275 | 6480464 | pirinixic acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:16306350 |
| pirinixic acid | multiple interactions | ISO | RGD:11275 | 6480464 | pirinixic acid inhibits the reaction [Cisplatin results in increased expression of CCL2 mRNA] | CTD | PMID:15814532 |
| pirinixic acid | affects expression | ISO | RGD:11275 | 6480464 | pirinixic acid affects the expression of CCL2 mRNA | CTD | PMID:16306350 |
| pitavastatin | multiple interactions | ISO | RGD:11275 | 6480464 | pitavastatin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:18323514 |
| pravastatin | multiple interactions | ISO | RGD:11275 | 6480464 | Pravastatin inhibits the reaction [LEP gene mutant form results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:18323514 |
| prednisolone | decreases expression | EXP | | 6480464 | Prednisolone results in decreased expression of CCL2 protein | CTD | PMID:20116850 |
| pregnenolone 16alpha-carbonitrile | multiple interactions | ISO | RGD:11275 | 6480464 | NR1I2 protein promotes the reaction [Pregnenolone Carbonitrile results in decreased expression of CCL2 mRNA] | CTD | PMID:22698814 |
| pregnenolone 16alpha-carbonitrile | decreases expression | ISO | RGD:11275 | 6480464 | Pregnenolone Carbonitrile results in decreased expression of CCL2 mRNA | CTD | PMID:22698814 |
| probenecid | multiple interactions | ISO | RGD:3645 | 6480464 | Probenecid inhibits the reaction [Uric Acid results in increased expression of CCL2 protein] | CTD | PMID:16113518 |
| progesterone | multiple interactions | EXP | | 6480464 | Progesterone inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of CCL2 protein] | CTD | PMID:22014880 |
| progesterone | affects expression | ISO | RGD:11275 | 6480464 | Progesterone affects the expression of CCL2 mRNA | CTD | PMID:17251523 |
| propan-2-ol | multiple interactions | ISO | RGD:11275 | 6480464 | 2-Propanol inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of CCL2 protein] | CTD | PMID:22020770 |
| propan-2-ol | multiple interactions | EXP | | 6480464 | 2-Propanol inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased secretion of CCL2 protein] | CTD | PMID:22020770 |
| propidium | decreases expression | EXP | | 6480464 | Propidium results in decreased expression of CCL2 protein | CTD | PMID:20116850 |
| prostaglandin E2 | multiple interactions | EXP | | 6480464 | Dinoprostone inhibits the reaction [Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]]]; more ... | CTD | PMID:21913898 |
| prostaglandin E2 | decreases expression | EXP | | 6480464 | Dinoprostone results in decreased expression of CCL2 mRNA | CTD | PMID:16303787 |
| prostaglandin I2 | increases expression | EXP | | 6480464 | Epoprostenol results in increased expression of CCL2 protein | CTD | PMID:15302794 |
| puromycin | decreases expression | EXP | | 6480464 | Puromycin results in decreased expression of CCL2 protein | CTD | PMID:20116850 |
| quartz | increases expression | ISO | RGD:3645 | 6480464 | Quartz results in increased expression of CCL2 mRNA | CTD | PMID:19836432 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with TNF protein] results in increased expression of CCL2 mRNA] | CTD | PMID:17880982 |
| quercetin | increases secretion | EXP | | 6480464 | Quercetin results in increased secretion of CCL2 protein | CTD | PMID:21371465 |
| quercetin | decreases secretion | EXP | | 6480464 | Quercetin results in decreased secretion of CCL2 protein | CTD | PMID:17191019 more ... |
| quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of CCL2 mRNA | CTD | PMID:21371465 |
| quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of CCL2 mRNA | CTD | PMID:21756928 PMID:21967610 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | CTD | PMID:21371465 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [PD168393 results in increased expression of CCL2 mRNA] | CTD | PMID:21967610 |
| quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of CCL2 mRNA | CTD | PMID:21756928 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA] | CTD | PMID:21756928 |
| quercetin | decreases secretion | EXP | | 6480464 | Quercetin results in decreased secretion of CCL2 protein | CTD | PMID:20816778 PMID:17191019 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | CTD | PMID:18489909 PMID:16794257 |
| quercetin | decreases secretion | EXP | | 6480464 | Quercetin results in decreased secretion of CCL2 protein | CTD | PMID:17191019 PMID:20816778 |
| quercetin | decreases expression | ISO | RGD:3645 | 6480464 | Quercetin results in decreased expression of CCL2 protein | CTD | PMID:11053056 |
| quercetin | decreases expression | ISO | RGD:3645 | 6480464 | Quercetin results in decreased expression of CCL2 mRNA | CTD | PMID:10925121 |
| quercetin | multiple interactions | ISO | RGD:3645 | 6480464 | Quercetin inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] | CTD | PMID:10541287 |
| quercetin | decreases expression | ISO | RGD:11275 | 6480464 | Quercetin results in decreased expression of CCL2 protein | CTD | PMID:16794257 |
| quercetin | multiple interactions | ISO | RGD:11275 | 6480464 | Quercetin inhibits the reaction [Vitamin E deficiency results in increased expression of CCL2 protein] | CTD | PMID:19735175 |
| quercetin | multiple interactions | ISO | RGD:11275 | 6480464 | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | CTD | PMID:22210036 |
| quercetin | decreases secretion | EXP | | 6480464 | Quercetin results in decreased secretion of CCL2 protein | CTD | PMID:17191019 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | CTD | PMID:16794257 PMID:18489909 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [S100B protein results in increased expression of CCL2 mRNA] | CTD | PMID:17103373 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | CTD | PMID:18489909 |
| quercetin 3-O-beta-D-glucoside | multiple interactions | ISO | RGD:3645 | 6480464 | isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCL2 mRNA] | CTD | PMID:21295105 |
| raloxifene | multiple interactions | EXP | | 6480464 | fulvestrant inhibits the reaction [Raloxifene results in decreased activity of CCL2 protein] | CTD | PMID:17006379 |
| raloxifene | decreases activity | EXP | | 6480464 | Raloxifene results in decreased activity of CCL2 protein | CTD | PMID:17006379 |
| raloxifene | multiple interactions | EXP | | 6480464 | [Raloxifene co-treated with ESR2 protein] results in increased expression of CCL2 mRNA | CTD | PMID:19059307 |
| raloxifene | affects expression | EXP | | 6480464 | Raloxifene affects the expression of CCL2 mRNA | CTD | PMID:14699072 |
| ramipril | multiple interactions | EXP | | 6480464 | [Simvastatin co-treated with Ramipril] results in decreased expression of CCL2 protein | CTD | PMID:15184351 |
| razoxane | multiple interactions | ISO | RGD:3645 | 6480464 | Razoxane inhibits the reaction [Doxorubicin results in increased expression of CCL2 mRNA] | CTD | PMID:19915844 |
| rel-(3R,5S)-fluvastatin | multiple interactions | ISO | RGD:3645 | 6480464 | fluvastatin inhibits the reaction [Puromycin Aminonucleoside results in increased expression of CCL2 mRNA] | CTD | PMID:16452496 |
| resveratrol | multiple interactions | ISO | RGD:11275 | 6480464 | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | CTD | PMID:19279313 more ... |
| resveratrol | decreases expression | ISO | RGD:3645 | 6480464 | resveratrol results in decreased expression of CCL2 protein | CTD | PMID:20709957 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:17191021 PMID:20531350 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | CTD | PMID:21371465 |
| resveratrol | decreases expression | ISO | RGD:3645 | 6480464 | resveratrol results in decreased expression of CCL2 mRNA | CTD | PMID:20050970 |
| resveratrol | multiple interactions | ISO | RGD:11275 | 6480464 | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:19293636 |
| resveratrol | decreases secretion | ISO | RGD:3645 | 6480464 | resveratrol results in decreased secretion of CCL2 protein | CTD | PMID:20050970 |
| resveratrol | multiple interactions | ISO | RGD:11275 | 6480464 | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; more ... | CTD | PMID:19293636 PMID:20712904 |
| resveratrol | multiple interactions | ISO | RGD:11275 | 6480464 | resveratrol inhibits the reaction [Calcium Chloride results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:21530968 |
| resveratrol | multiple interactions | ISO | RGD:11275 | 6480464 | [resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of CCL2 mRNA | CTD | PMID:16806235 |
| resveratrol | decreases secretion | EXP | | 6480464 | resveratrol results in decreased secretion of CCL2 protein | CTD | PMID:21967610 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CCL2 mRNA | CTD | PMID:21371465 more ... |
| resveratrol | multiple interactions | EXP | | 6480464 | sirtinol inhibits the reaction [resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]] | CTD | PMID:20531350 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | CTD | PMID:22414048 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [PD168393 results in increased expression of CCL2 mRNA] | CTD | PMID:21967610 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CCL2 mRNA | CTD | PMID:21756928 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA] | CTD | PMID:21756928 |
| resveratrol | multiple interactions | ISO | RGD:3645 | 6480464 | resveratrol affects the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of CCL2 mRNA] | CTD | PMID:15734790 |
| resveratrol | decreases expression | ISO | RGD:11275 | 6480464 | resveratrol results in decreased expression of CCL2 protein | CTD | PMID:17872969 |
| resveratrol | multiple interactions | ISO | RGD:11275 | 6480464 | resveratrol inhibits the reaction [stearic acid results in increased expression of CCL2 mRNA] | CTD | PMID:17374693 |
| resveratrol | multiple interactions | ISO | RGD:11275 | 6480464 | resveratrol inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | CTD | PMID:22118570 |
| resveratrol | decreases expression | ISO | RGD:11275 | 6480464 | resveratrol analog results in decreased expression of CCL2 mRNA | CTD | PMID:15652768 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [CCL2 protein affects the localization of Calcium] | CTD | PMID:16212921 |
| resveratrol | multiple interactions | EXP | | 6480464 | Pertussis Toxin inhibits the reaction [resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]]; more ... | CTD | PMID:17191021 |
| rolipram | multiple interactions | ISO | RGD:3645 | 6480464 | Rolipram inhibits the reaction [Oxygen results in increased expression of CCL2 protein] | CTD | PMID:18941502 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCL2 mRNA | CTD | PMID:20847119 |
| rosiglitazone | decreases expression | ISO | RGD:3645 | 6480464 | rosiglitazone results in decreased expression of CCL2 mRNA | CTD | PMID:17394460 PMID:21515302 |
| rosiglitazone | decreases expression | ISO | RGD:3645 | 6480464 | rosiglitazone results in decreased expression of CCL2 mRNA | CTD | PMID:17394460 |
| rosiglitazone | decreases expression | ISO | RGD:11275 | 6480464 | rosiglitazone results in decreased expression of CCL2 mRNA | CTD | PMID:16306350 PMID:17394460 |
| rosiglitazone | multiple interactions | ISO | RGD:11275 | 6480464 | rosiglitazone inhibits the reaction [Caerulein results in increased expression of CCL2 mRNA] | CTD | PMID:17463185 |
| rosiglitazone | increases expression | ISO | RGD:3645 | 6480464 | rosiglitazone results in increased expression of CCL2 mRNA | CTD | PMID:20623750 |
| rosiglitazone | multiple interactions | ISO | RGD:3645 | 6480464 | rosiglitazone inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | CTD | PMID:18413206 |
| rosiglitazone | multiple interactions | ISO | RGD:11275 | 6480464 | rosiglitazone inhibits the reaction [Ethanol results in increased expression of CCL2 mRNA] | CTD | PMID:22173916 |
| rosiglitazone | multiple interactions | ISO | RGD:11275 | 6480464 | rosiglitazone inhibits the reaction [Bleomycin results in increased expression of CCL2 protein] | CTD | PMID:19147827 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [IFNG results in increased expression of CCL2 mRNA] | CTD | PMID:21268089 |
| rosiglitazone | multiple interactions | ISO | RGD:11275 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA; more ... | CTD | PMID:16054899 |
| rosiglitazone | decreases expression | ISO | RGD:11275 | 6480464 | rosiglitazone results in decreased expression of CCL2 mRNA | CTD | PMID:16306350 |
| rosuvastatin | decreases expression | ISO | RGD:3645 | 6480464 | rosuvastatin results in decreased expression of CCL2 mRNA | CTD | PMID:15681303 |
| rutin | decreases expression | EXP | | 6480464 | Rutin results in decreased expression of CCL2 mRNA | CTD | PMID:21756928 |
| rutin | decreases secretion | EXP | | 6480464 | Rutin results in decreased secretion of CCL2 protein | CTD | PMID:21967610 |
| rutin | decreases expression | EXP | | 6480464 | Rutin results in decreased expression of CCL2 mRNA | CTD | PMID:21756928 PMID:21967610 |
| rutin | multiple interactions | EXP | | 6480464 | Rutin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA] | CTD | PMID:21756928 |
| salmeterol | multiple interactions | EXP | | 6480464 | salmeterol promotes the reaction [15-deoxyprostaglandin J2 inhibits the reaction [TNF protein results in increased expression of CCL2 protein]] | CTD | PMID:15531761 |
| selenium atom | multiple interactions | EXP | | 6480464 | Selenium inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:16143069 |
| selenium atom | multiple interactions | EXP | | 6480464 | [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of CCL2 mRNA | CTD | PMID:21481475 |
| sevoflurane | decreases expression | ISO | RGD:3645 | 6480464 | sevoflurane results in decreased expression of CCL2 mRNA | CTD | PMID:15564938 |
| silicon dioxide | increases expression | ISO | RGD:3645 | 6480464 | Silicon Dioxide results in increased expression of CCL2 protein | CTD | PMID:21602193 |
| silicon dioxide | increases expression | ISO | RGD:3645 | 6480464 | Silicon Dioxide results in increased expression of CCL2 protein | CTD | PMID:21602193 PMID:22861000 |
| silicon dioxide | multiple interactions | ISO | RGD:11275 | 6480464 | [Silicon Dioxide co-treated with Lipopolysaccharides] results in increased secretion of CCL2 protein | CTD | PMID:22273745 PMID:22815821 |
| silicon dioxide | multiple interactions | ISO | RGD:11275 | 6480464 | Acetylcysteine inhibits the reaction [[Silicon Dioxide co-treated with Lipopolysaccharides] results in increased secretion of CCL2 protein] | CTD | PMID:22815821 |
| silicon dioxide | multiple interactions | ISO | RGD:11275 | 6480464 | [Gold co-treated with Silicon Dioxide] results in increased secretion of CCL2 protein | CTD | PMID:22155353 |
| silicon dioxide | increases secretion | ISO | RGD:11275 | 6480464 | Silicon Dioxide results in increased secretion of CCL2 protein | CTD | PMID:22273745 |
| silicon dioxide | multiple interactions | ISO | RGD:11275 | 6480464 | AHR protein affects the reaction [[Silicon Dioxide co-treated with Lipopolysaccharides] results in increased secretion of CCL2 protein]; more ... | CTD | PMID:22273745 |
| silicon dioxide | increases expression | ISO | RGD:11275 | 6480464 | Silicon Dioxide results in increased expression of CCL2 mRNA | CTD | PMID:19073995 |
| simvastatin | multiple interactions | EXP | | 6480464 | [Simvastatin co-treated with Ramipril] results in decreased expression of CCL2 protein | CTD | PMID:15184351 |
| simvastatin | decreases expression | ISO | RGD:3645 | 6480464 | Simvastatin results in decreased expression of CCL2 mRNA | CTD | PMID:16414398 more ... |
| simvastatin | decreases expression | EXP | | 6480464 | Simvastatin results in decreased expression of CCL2 mRNA | CTD | PMID:12117737 more ... |
| simvastatin | decreases expression | ISO | RGD:3645 | 6480464 | Simvastatin results in decreased expression of CCL2 mRNA | CTD | PMID:15855201 more ... |
| simvastatin | decreases expression | EXP | | 6480464 | Simvastatin results in decreased expression of CCL2 mRNA | CTD | PMID:19225232 more ... |
| simvastatin | decreases expression | ISO | RGD:3645 | 6480464 | Simvastatin results in decreased expression of CCL2 protein | CTD | PMID:18309148 PMID:17449418 |
| simvastatin | decreases expression | ISO | RGD:3645 | 6480464 | Simvastatin results in decreased expression of CCL2 mRNA | CTD | PMID:22305382 more ... |
| simvastatin | decreases expression | EXP | | 6480464 | Simvastatin results in decreased expression of CCL2 protein | CTD | PMID:12117737 PMID:15184351 |
| simvastatin | decreases expression | EXP | | 6480464 | Simvastatin results in decreased expression of CCL2 mRNA | CTD | PMID:12117737 more ... |
| simvastatin | multiple interactions | EXP | | 6480464 | Simvastatin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | CTD | PMID:15824212 PMID:16443229 |
| simvastatin | decreases expression | ISO | RGD:3645 | 6480464 | Simvastatin results in decreased expression of CCL2 protein | CTD | PMID:17449418 PMID:18309148 |
| simvastatin | decreases expression | ISO | RGD:3645 | 6480464 | Simvastatin results in decreased expression of CCL2 mRNA | CTD | PMID:15855201 more ... |
| simvastatin | affects expression | ISO | RGD:11275 | 6480464 | Simvastatin affects the expression of CCL2 mRNA | CTD | PMID:12818400 |
| simvastatin | decreases expression | ISO | RGD:11275 | 6480464 | Simvastatin results in decreased expression of CCL2 mRNA | CTD | PMID:19262002 |
| simvastatin | decreases expression | EXP | | 6480464 | Simvastatin results in decreased expression of CCL2 protein | CTD | PMID:15184351 PMID:12117737 |
| simvastatin | decreases expression | EXP | | 6480464 | Simvastatin results in decreased expression of CCL2 mRNA | CTD | PMID:19225232 more ... |
| simvastatin | multiple interactions | EXP | | 6480464 | Simvastatin inhibits the reaction [TNF results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:16321392 PMID:12117737 |
| simvastatin | multiple interactions | EXP | | 6480464 | Simvastatin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | CTD | PMID:16443229 PMID:15824212 |
| simvastatin | multiple interactions | EXP | | 6480464 | Simvastatin inhibits the reaction [IFNG results in increased expression of CCL2 mRNA] | CTD | PMID:16321392 PMID:21268089 |
| simvastatin | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [IFNG results in increased expression of CCL2 mRNA]]; more ... | CTD | PMID:16321392 |
| simvastatin | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased expression of CCL2 mRNA]] | CTD | PMID:12117737 PMID:16321392 |
| simvastatin | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin results in decreased expression of CCL2 mRNA]; more ... | CTD | PMID:12117737 |
| simvastatin | decreases expression | EXP | | 6480464 | Simvastatin results in decreased expression of CCL2 protein | CTD | PMID:15184351 |
| simvastatin | decreases response to substance | EXP | | 6480464 | Simvastatin results in decreased susceptibility to CCL2 protein | CTD | PMID:15781755 |
| simvastatin | multiple interactions | EXP | | 6480464 | Simvastatin inhibits the reaction [AGT protein results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:19225232 |
| simvastatin | decreases expression | EXP | | 6480464 | Simvastatin results in decreased expression of CCL2 mRNA | CTD | PMID:19225232 |
| sodium atom | multiple interactions | ISO | RGD:3645 | 6480464 | Sodium deficiency inhibits the reaction [ALB protein results in increased expression of CCL2 protein]; more ... | CTD | PMID:11340305 |
| sodium dichromate | decreases expression | EXP | | 6480464 | sodium bichromate results in decreased expression of CCL2 mRNA | CTD | PMID:12760830 |
| sodium dodecyl sulfate | decreases expression | EXP | | 6480464 | Sodium Dodecyl Sulfate results in decreased expression of CCL2 mRNA | CTD | PMID:20713136 |
| stavudine | increases expression | EXP | | 6480464 | Stavudine results in increased expression of CCL2 protein | CTD | PMID:17668557 |
| stearic acid | increases expression | ISO | RGD:11275 | 6480464 | stearic acid results in increased expression of CCL2 mRNA | CTD | PMID:17374693 |
| stearic acid | multiple interactions | ISO | RGD:11275 | 6480464 | resveratrol inhibits the reaction [stearic acid results in increased expression of CCL2 mRNA] | CTD | PMID:17374693 |
| streptozocin | increases expression | ISO | RGD:11275 | 6480464 | Streptozocin results in increased expression of CCL2 | CTD | PMID:16374426 |
| streptozocin | increases expression | ISO | RGD:3645 | 6480464 | Streptozocin results in increased expression of CCL2 mRNA | CTD | PMID:15284299 more ... |
| streptozocin | increases expression | ISO | RGD:3645 | 6480464 | Streptozocin results in increased expression of CCL2 mRNA | CTD | PMID:15284299 more ... |
| streptozocin | increases expression | ISO | RGD:3645 | 6480464 | Streptozocin results in increased expression of CCL2 protein | CTD | PMID:18999900 PMID:17624267 |
| streptozocin | increases expression | ISO | RGD:3645 | 6480464 | Streptozocin results in increased expression of CCL2 mRNA | CTD | PMID:17624267 more ... |
| streptozocin | multiple interactions | ISO | RGD:3645 | 6480464 | valsartan inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | CTD | PMID:17624267 PMID:15284299 |
| streptozocin | increases expression | ISO | RGD:3645 | 6480464 | Streptozocin results in increased expression of CCL2 mRNA | CTD | PMID:15284299 more ... |
| streptozocin | increases expression | ISO | RGD:3645 | 6480464 | Streptozocin results in increased expression of CCL2 mRNA | CTD | PMID:16684804 more ... |
| streptozocin | multiple interactions | ISO | RGD:3645 | 6480464 | rosiglitazone inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | CTD | PMID:18413206 |
| streptozocin | multiple interactions | ISO | RGD:3645 | 6480464 | valsartan inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | CTD | PMID:15284299 PMID:17624267 |
| streptozocin | multiple interactions | ISO | RGD:3645 | 6480464 | vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | CTD | PMID:16684804 |
| streptozocin | increases expression | ISO | RGD:3645 | 6480464 | Streptozocin results in increased expression of CCL2 protein | CTD | PMID:17624267 PMID:18999900 |
| streptozocin | increases expression | ISO | RGD:3645 | 6480464 | Streptozocin results in increased expression of CCL2 mRNA | CTD | PMID:17624267 more ... |
| streptozocin | multiple interactions | ISO | RGD:3645 | 6480464 | Pentoxifylline inhibits the reaction [Streptozocin results in increased expression of CCL2 protein] | CTD | PMID:19921414 |
| streptozocin | multiple interactions | ISO | RGD:3645 | 6480464 | PD 123319 inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:15284299 |
| streptozocin | multiple interactions | ISO | RGD:3645 | 6480464 | mycophenolate mofetil inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:17624267 |
| streptozocin | affects response to substance | ISO | RGD:11275 | 6480464 | CCL2 affects the susceptibility to Streptozocin | CTD | PMID:16374426 |
| styrene | increases expression | EXP | | 6480464 | Styrene results in increased expression of CCL2 mRNA | CTD | PMID:15212811 |
| styrene | increases expression | EXP | | 6480464 | Styrene results in increased expression of CCL2 protein | CTD | PMID:15212811 PMID:17993253 |
| succimer | multiple interactions | ISO | RGD:11275 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL2 mRNA | CTD | PMID:21641980 |
| sulfapyridine | decreases secretion | EXP | | 6480464 | Sulfapyridine results in decreased secretion of CCL2 protein | CTD | PMID:12231210 |
| sumatriptan | multiple interactions | ISO | RGD:3645 | 6480464 | [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CCL2 protein]; more ... | CTD | PMID:22150557 |
| superoxide | multiple interactions | EXP | | 6480464 | Superoxides affects the reaction [Fructose results in increased secretion of CCL2 protein] | CTD | PMID:19158351 |
| superoxide | increases expression | ISO | RGD:11275 | 6480464 | Superoxides results in increased expression of CCL2 mRNA | CTD | PMID:8856246 |
| superoxide | multiple interactions | ISO | RGD:11275 | 6480464 | 1,3-dimethylthiourea inhibits the reaction [Superoxides results in increased expression of CCL2 mRNA] | CTD | PMID:8856246 |
| tacrolimus hydrate | multiple interactions | ISO | RGD:3645 | 6480464 | pyrrolidine dithiocarbamic acid inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA] | CTD | PMID:12472797 |
| tacrolimus hydrate | increases expression | ISO | RGD:3645 | 6480464 | Tacrolimus results in increased expression of CCL2 mRNA | CTD | PMID:12472797 |
| tamoxifen | multiple interactions | EXP | | 6480464 | [Tamoxifen co-treated with ESR2 protein] results in increased expression of CCL2 mRNA | CTD | PMID:19059307 |
| tamoxifen | multiple interactions | ISO | RGD:11275 | 6480464 | Tamoxifen inhibits the reaction [Dietary Fats results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:23038002 |
| taurocholic acid | multiple interactions | ISO | RGD:11275 | 6480464 | EGR1 promotes the reaction [Taurocholic Acid results in increased expression of CCL2 mRNA] | CTD | PMID:21224055 |
| taurocholic acid | increases expression | ISO | RGD:11275 | 6480464 | Taurocholic Acid results in increased expression of CCL2 mRNA | CTD | PMID:21224055 |
| telmisartan | decreases expression | ISO | RGD:3645 | 6480464 | telmisartan results in decreased expression of CCL2 protein | CTD | PMID:17922026 |
| telmisartan | multiple interactions | EXP | | 6480464 | telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:22124178 |
| temozolomide | affects response to substance | EXP | | 6480464 | CCL2 mRNA affects the susceptibility to temozolomide | CTD | PMID:16365179 |
| temozolomide | affects activity | EXP | | 6480464 | temozolomide affects the activity of CCL2 protein | CTD | PMID:17522861 |
| temozolomide | decreases expression | EXP | | 6480464 | temozolomide results in decreased expression of CCL2 protein | CTD | PMID:17522861 |
| tert-butyl hydroperoxide | multiple interactions | EXP | | 6480464 | [pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCL2 mRNA; more ... | CTD | PMID:20847119 |
| tert-butyl hydroperoxide | decreases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in decreased expression of CCL2 mRNA | CTD | PMID:20847119 |
| testosterone | increases expression | ISO | RGD:11275 | 6480464 | Testosterone results in increased expression of CCL2 mRNA | CTD | PMID:15788153 |
| tetrachloromethane | increases expression | ISO | RGD:11275 | 6480464 | Carbon Tetrachloride results in increased expression of CCL2 mRNA | CTD | PMID:12500195 PMID:17125873 |
| tetrachloromethane | multiple interactions | ISO | RGD:3645 | 6480464 | Curcumin inhibits the reaction [Carbon Tetrachloride results in increased expression of CCL2 mRNA] | CTD | PMID:22683883 |
| tetrachloromethane | increases expression | ISO | RGD:3645 | 6480464 | Carbon Tetrachloride results in increased expression of CCL2 mRNA | CTD | PMID:22683883 |
| tetrachloromethane | multiple interactions | ISO | RGD:11275 | 6480464 | GW0742 inhibits the reaction [Carbon Tetrachloride results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:18622026 |
| tetrachloromethane | increases expression | ISO | RGD:11275 | 6480464 | Carbon Tetrachloride results in increased expression of CCL2 mRNA | CTD | PMID:12500195 more ... |
| tetrachloromethane | increases expression | ISO | RGD:11275 | 6480464 | Carbon Tetrachloride results in increased expression of CCL2 protein | CTD | PMID:22206755 |
| tetrachloromethane | increases expression | ISO | RGD:11275 | 6480464 | Carbon Tetrachloride results in increased expression of CCL2 mRNA | CTD | PMID:12500195 more ... |
| tetrachloromethane | multiple interactions | ISO | RGD:11275 | 6480464 | TBXA2R protein affects the reaction [Carbon Tetrachloride results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:22206755 |
| tetrachloromethane | multiple interactions | ISO | RGD:11275 | 6480464 | ginsan inhibits the reaction [Carbon Tetrachloride results in increased expression of CCL2 mRNA] | CTD | PMID:19913046 |
| tetrachloromethane | increases expression | ISO | RGD:11275 | 6480464 | Carbon Tetrachloride results in increased expression of CCL2 mRNA | CTD | PMID:12500195 more ... |
| tetrachloromethane | multiple interactions | ISO | RGD:11275 | 6480464 | FOXF1A protein affects the reaction [Carbon Tetrachloride results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:12500195 |
| tetrachloromethane | increases expression | ISO | RGD:11275 | 6480464 | Carbon Tetrachloride results in increased expression of CCL2 mRNA | CTD | PMID:17125873 PMID:12500195 |
| tetrachloromethane | multiple interactions | ISO | RGD:11275 | 6480464 | CCL2 gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of LTB mRNA]; more ... | CTD | PMID:17125873 |
| tetrathiomolybdate(2-) | multiple interactions | ISO | RGD:11275 | 6480464 | tetrathiomolybdate inhibits the reaction [Bleomycin results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:15541506 |
| tetrathiomolybdate(2-) | multiple interactions | ISO | RGD:11275 | 6480464 | tetrathiomolybdate inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of and results in increased expression of CCL2 protein]; more ... | CTD | PMID:21724870 |
| thalidomide | decreases expression | EXP | | 6480464 | Thalidomide analog results in decreased expression of CCL2 mRNA | CTD | PMID:20525221 |
| thapsigargin | multiple interactions | ISO | RGD:11275 | 6480464 | Thapsigargin inhibits the reaction [1-Methyl-3-isobutylxanthine results in decreased expression of CCL2 mRNA] | CTD | PMID:19141685 |
| thapsigargin | increases expression | EXP | | 6480464 | Thapsigargin results in increased expression of CCL2 mRNA | CTD | PMID:18951912 |
| thapsigargin | increases expression | ISO | RGD:11275 | 6480464 | Thapsigargin results in increased expression of CCL2 mRNA | CTD | PMID:8764118 |
| thapsigargin | decreases expression | ISO | RGD:3645 | 6480464 | Thapsigargin results in decreased expression of CCL2 mRNA | CTD | PMID:20830808 |
| thapsigargin | multiple interactions | ISO | RGD:11275 | 6480464 | Thapsigargin inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:18799549 |
| theophylline | multiple interactions | EXP | | 6480464 | [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of CCL2 protein | CTD | PMID:18951874 |
| thioacetamide | multiple interactions | ISO | RGD:3645 | 6480464 | Iron, Dietary affects the reaction [Thioacetamide affects the expression of CCL2 mRNA] | CTD | PMID:18032466 |
| thioacetamide | increases expression | ISO | RGD:3645 | 6480464 | Thioacetamide results in increased expression of CCL2 mRNA | CTD | PMID:19389872 |
| titanium atom | increases expression | EXP | | 6480464 | Titanium results in increased expression of CCL2 mRNA | CTD | PMID:16392133 |
| titanium atom | multiple interactions | ISO | RGD:11275 | 6480464 | Titanium promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | CTD | PMID:20682337 |
| titanium atom | increases secretion | EXP | | 6480464 | Titanium results in increased secretion of CCL2 protein | CTD | PMID:16392133 |
| titanium dioxide | increases expression | ISO | RGD:11275 | 6480464 | titanium dioxide results in increased expression of CCL2 mRNA; more ... | CTD | PMID:19464567 |
| titanium dioxide | increases expression | ISO | RGD:3645 | 6480464 | titanium dioxide results in increased expression of CCL2 | CTD | PMID:22939914 |
| titanium dioxide | increases expression | ISO | RGD:11275 | 6480464 | titanium dioxide results in increased expression of CCL2 mRNA | CTD | PMID:19464567 PMID:21259345 |
| titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of CCL2 mRNA | CTD | PMID:19695317 PMID:22342292 |
| titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of CCL2 mRNA | CTD | PMID:19695317 |
| toluene | multiple interactions | ISO | RGD:11275 | 6480464 | [Toluene co-treated with SERPINB14 protein] results in increased expression of CCL2 mRNA | CTD | PMID:19765639 |
| toluene 2,4-diisocyanate | increases expression | ISO | RGD:11275 | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of CCL2 protein | CTD | PMID:20219652 |
| toluene 2,4-diisocyanate | increases expression | ISO | RGD:11275 | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of CCL2 mRNA | CTD | PMID:19647056 |
| trans-resveratrol | multiple interactions | ISO | RGD:11275 | 6480464 | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | CTD | PMID:19279313 more ... |
| trans-resveratrol | decreases expression | ISO | RGD:3645 | 6480464 | resveratrol results in decreased expression of CCL2 protein | CTD | PMID:20709957 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:17191021 PMID:20531350 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | CTD | PMID:21371465 |
| trans-resveratrol | decreases expression | ISO | RGD:3645 | 6480464 | resveratrol results in decreased expression of CCL2 mRNA | CTD | PMID:20050970 |
| trans-resveratrol | multiple interactions | ISO | RGD:11275 | 6480464 | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:19293636 |
| trans-resveratrol | decreases secretion | ISO | RGD:3645 | 6480464 | resveratrol results in decreased secretion of CCL2 protein | CTD | PMID:20050970 |
| trans-resveratrol | multiple interactions | ISO | RGD:11275 | 6480464 | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; more ... | CTD | PMID:19293636 PMID:20712904 |
| trans-resveratrol | multiple interactions | ISO | RGD:11275 | 6480464 | resveratrol inhibits the reaction [Calcium Chloride results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:21530968 |
| trans-resveratrol | multiple interactions | ISO | RGD:11275 | 6480464 | [resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of CCL2 mRNA | CTD | PMID:16806235 |
| trans-resveratrol | decreases secretion | EXP | | 6480464 | resveratrol results in decreased secretion of CCL2 protein | CTD | PMID:21967610 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CCL2 mRNA | CTD | PMID:21371465 more ... |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | sirtinol inhibits the reaction [resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]] | CTD | PMID:20531350 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | CTD | PMID:22414048 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [PD168393 results in increased expression of CCL2 mRNA] | CTD | PMID:21967610 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CCL2 mRNA | CTD | PMID:21756928 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA] | CTD | PMID:21756928 |
| trans-resveratrol | multiple interactions | ISO | RGD:3645 | 6480464 | resveratrol affects the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of CCL2 mRNA] | CTD | PMID:15734790 |
| trans-resveratrol | decreases expression | ISO | RGD:11275 | 6480464 | resveratrol results in decreased expression of CCL2 protein | CTD | PMID:17872969 |
| trans-resveratrol | multiple interactions | ISO | RGD:11275 | 6480464 | resveratrol inhibits the reaction [stearic acid results in increased expression of CCL2 mRNA] | CTD | PMID:17374693 |
| trans-resveratrol | multiple interactions | ISO | RGD:11275 | 6480464 | resveratrol inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | CTD | PMID:22118570 |
| trans-resveratrol | decreases expression | ISO | RGD:11275 | 6480464 | resveratrol analog results in decreased expression of CCL2 mRNA | CTD | PMID:15652768 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [CCL2 protein affects the localization of Calcium] | CTD | PMID:16212921 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | Pertussis Toxin inhibits the reaction [resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]]; more ... | CTD | PMID:17191021 |
| trimethyltin | increases expression | ISO | RGD:11275 | 6480464 | trimethyltin results in increased expression of CCL2 mRNA | CTD | PMID:21435392 |
| triphenylstannane | increases expression | EXP | | 6480464 | triphenyltin results in increased expression of CCL2 mRNA | CTD | PMID:12788061 |
| troglitazone | multiple interactions | EXP | | 6480464 | troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]]; more ... | CTD | PMID:20847119 |
| troglitazone | decreases expression | ISO | RGD:3645 | 6480464 | troglitazone results in decreased expression of CCL2 mRNA | CTD | PMID:21515302 |
| troglitazone | decreases expression | ISO | RGD:11275 | 6480464 | troglitazone results in decreased expression of CCL2 mRNA | CTD | PMID:12468449 |
| troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of CCL2 mRNA | CTD | PMID:19140230 |
| troglitazone | multiple interactions | ISO | RGD:11275 | 6480464 | troglitazone promotes the reaction [Capsaicin results in decreased secretion of CCL2 protein] | CTD | PMID:17719033 |
| troglitazone | multiple interactions | EXP | | 6480464 | troglitazone inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | CTD | PMID:15531761 |
| tunicamycin | multiple interactions | ISO | RGD:11275 | 6480464 | Tunicamycin inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | CTD | PMID:18799549 |
| tunicamycin | multiple interactions | ISO | RGD:11275 | 6480464 | Tunicamycin inhibits the reaction [1-Methyl-3-isobutylxanthine results in decreased expression of CCL2 mRNA] | CTD | PMID:19141685 |
| undecane | increases expression | ISO | RGD:3645 | 6480464 | undecane results in increased expression of CCL2 protein | CTD | PMID:17337753 |
| uranium atom | decreases expression | ISO | RGD:3645 | 6480464 | Uranium results in decreased expression of CCL2 protein | CTD | PMID:16854789 |
| uranium atom | decreases expression | ISO | RGD:3645 | 6480464 | Uranium results in decreased expression of CCL2 mRNA | CTD | PMID:17566059 |
| uric acid | multiple interactions | EXP | | 6480464 | Allopurinol inhibits the reaction [[Fructose co-treated with Uric Acid] results in increased secretion of CCL2 protein] | CTD | PMID:19158351 |
| uric acid | increases expression | ISO | RGD:3645 | 6480464 | Uric Acid results in increased expression of CCL2 protein | CTD | PMID:16113518 |
| uric acid | multiple interactions | ISO | RGD:3645 | 6480464 | Probenecid inhibits the reaction [Uric Acid results in increased expression of CCL2 protein] | CTD | PMID:16113518 |
| uric acid | increases secretion | EXP | | 6480464 | Uric Acid results in increased secretion of CCL2 protein | CTD | PMID:19158351 |
| ursodeoxycholic acid | multiple interactions | EXP | | 6480464 | Ursodeoxycholic Acid analog inhibits the reaction [TNF protein promotes the reaction [Cycloheximide results in increased expression of CCL2 mRNA]] | CTD | PMID:21146893 |
| ursodeoxycholic acid | multiple interactions | ISO | RGD:11275 | 6480464 | Ursodeoxycholic Acid analog inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:21146893 |
| valsartan | multiple interactions | EXP | | 6480464 | [valsartan co-treated with Simvastatin] inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]]; more ... | CTD | PMID:19225232 |
| valsartan | multiple interactions | EXP | | 6480464 | valsartan inhibits the reaction [AGT protein results in increased expression of CCL2 mRNA] | CTD | PMID:19225232 PMID:16705055 |
| valsartan | multiple interactions | ISO | RGD:3645 | 6480464 | valsartan inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | CTD | PMID:15284299 PMID:17624267 |
| valsartan | multiple interactions | ISO | RGD:3645 | 6480464 | valsartan inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | CTD | PMID:17624267 PMID:15284299 |
| valsartan | multiple interactions | ISO | RGD:3645 | 6480464 | valsartan inhibits the reaction [Streptozocin results in increased expression of CCL2 protein] | CTD | PMID:17624267 |
| valsartan | multiple interactions | ISO | RGD:11275 | 6480464 | valsartan inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 mRNA] | CTD | PMID:18436887 |
| valsartan | multiple interactions | EXP | | 6480464 | valsartan inhibits the reaction [AGT protein results in increased expression of CCL2 protein] | CTD | PMID:16705055 |
| valsartan | multiple interactions | EXP | | 6480464 | valsartan inhibits the reaction [AGT protein results in increased expression of CCL2 mRNA] | CTD | PMID:16705055 PMID:19225232 |
| vanadyl sulfate | increases expression | EXP | | 6480464 | vanadyl sulfate results in increased expression of CCL2 mRNA | CTD | PMID:16330358 |
| vanadyl sulfate | multiple interactions | ISO | RGD:3645 | 6480464 | vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | CTD | PMID:16684804 |
| vincaleukoblastine | increases expression | ISO | RGD:3645 | 6480464 | Vinblastine results in increased expression of CCL2 mRNA | CTD | PMID:20624997 |
| vincristine | increases expression | ISO | RGD:3645 | 6480464 | Vincristine results in increased expression of CCL2 mRNA | CTD | PMID:20624997 |
| wortmannin | multiple interactions | ISO | RGD:11275 | 6480464 | wortmannin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | CTD | PMID:22225513 |
| zalcitabine | increases expression | ISO | RGD:3645 | 6480464 | Zalcitabine results in increased expression of CCL2 protein | CTD | PMID:17761732 |
| zidovudine | increases expression | EXP | | 6480464 | Zidovudine results in increased expression of CCL2 protein | CTD | PMID:17668557 |
| zinc atom | decreases expression | EXP | | 6480464 | Zinc results in decreased expression of CCL2 protein | CTD | PMID:18215484 PMID:20427734 |
| zinc atom | multiple interactions | EXP | | 6480464 | IL6 promoter polymorphism affects the reaction [Zinc results in decreased expression of CCL2 protein]; more ... | CTD | PMID:18215484 |
| zinc atom | decreases expression | EXP | | 6480464 | Zinc results in decreased expression of CCL2 protein | CTD | PMID:18215484 |
| zinc oxide | increases expression | ISO | RGD:11275 | 6480464 | Zinc Oxide analog results in increased expression of CCL2 protein | CTD | PMID:20851137 |
| zinc(0) | decreases expression | EXP | | 6480464 | Zinc results in decreased expression of CCL2 protein | CTD | PMID:18215484 PMID:20427734 |
| zinc(0) | multiple interactions | EXP | | 6480464 | IL6 promoter polymorphism affects the reaction [Zinc results in decreased expression of CCL2 protein]; more ... | CTD | PMID:18215484 |
| zinc(0) | decreases expression | EXP | | 6480464 | Zinc results in decreased expression of CCL2 protein | CTD | PMID:18215484 |
| zoledronic acid | multiple interactions | EXP | | 6480464 | zoledronic acid promotes the reaction [Gossypol results in decreased expression of CCL2 mRNA] | CTD | PMID:19825521 |